<?xml version="1.0" encoding="iso-8859-1"?>
		<rss version="2.0" >
        <channel>
        <title>rellease ID</title>
        <link>https://relleaseid.com/</link>
        <description>situs relleaseID</description>
        <language>en-us</language>
        <pubDate>Sun, 11 Oct 2026 08:18:29 +0700</pubDate>
        <lastBuildDate>Sun, 11 Oct 2026 08:18:29 +0700</lastBuildDate>
        <generator>rellease ID RSS Generator</generator>
        <managingEditor>relleaseid@gmail.com</managingEditor>
        <webMaster>arie.vcr@gmail.com</webMaster>
		<image>
		<url>https://relleaseid.com/icon.gif</url>
		<title>rellease ID</title>
		<link>https://relleaseid.com/</link>
		<description>Fasilitas RSS dari relleaseID</description>
		</image>
<item>
<title>Documentary 2026: Towards the Hainan Free Trade Port Premieres in Kuala Lumpur, Encouraging ASEAN Businesses to Establish a Presence in Hainan</title>
<link>https://relleaseid.com/berita-bisnis/Documentary-2026--Towards-the-Hainan-Free-Trade-Port-Premieres-in-Kuala-Lumpur--Encouraging-ASEAN-Businesses-to-Establish-a-Presence-in-Hainan</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/2210_Documentary-2026--Towards-the-Hainan-Free-Trade-Port-Premieres-in-Kuala-Lumpur--Encouraging-ASEAN-Businesses-to-Establish-a-Presence-in-Hainan.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div><div>Documentary 2026: Towards the Hainan Free Trade Port Premieres in Kuala Lumpur, Encouraging ASEAN Businesses to Establish a Presence in Hainan</div><div><br></div><div><div>Issuer: Hainan International Media Center</div><div><br></div><div>HAIKOU, CHINA - Media OutReach Newswire - 9 October 2026 - On August 27, 2026, the documentary 2026: Towards the Hainan Free Trade Port, co-produced by the Malaysian National News Agency (Bernama) and the Hainan International Media Center (HIMC), premiered in Kuala Lumpur.</div></div></div><div><br></div><div>The documentary was broadcast during prime time on Bernama TV and simultaneously released across the agency&#039;s digital media platforms.</div><div><br></div><div>The 30-minute documentary was filmed by a Bernama reporting team in mid-July 2026 across multiple cities and counties in Hainan, including Haikou, Sanya and Danzhou. Focusing on the preferential policies of the Hainan Free Trade Port, it offers an in-depth look at the market opportunities for ASEAN businesses seeking to enter the Chinese mainland market through Hainan.</div><div><br></div><div> The documentary also highlights the Yangpu Economic Development Zone, showing how manufacturers can benefit from zero-tariff treatment for products with no less than 30% value added through processing under the "freer access at the first line, regulated access at the second line" customs supervision model.</div><div><br></div><div>ASEAN has been Hainan&#039;s largest trading partner for six consecutive years, with Hainan exporting to Indonesia, Malaysia, Thailand, Vietnam, Singapore, the Philippines and other ASEAN countries. Yangpu Port has also opened multiple direct shipping routes to Malaysia&#039;s Port Klang and Pasir Gudang Port. </div><div><br></div><div>The documentary further introduces Hainan&#039;s preferential tax policies - including a 15% corporate income tax rate for eligible enterprises and an individual income tax exemption for the portion of tax burden exceeding 15% for qualifying talent - duty-free imports of production equipment and raw materials, as well as efforts by the Sanya International Yacht Center to explore cross-border routes with Malaysia.</div><div><br></div><div>Hashtag: #Hainan</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div>   ]]></description>
<pubDate>Sun, 11 Oct 2026 07:11:00 +0700</pubDate>
</item>
<item>
<title>CGTN: How China uses digital tech to empower women globally</title>
<link>https://relleaseid.com/berita-bisnis/CGTN--How-China-uses-digital-tech-to-empower-women-globally</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4999_CGTN--How-China-uses-digital-tech-to-empower-women-globally.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>BEIJING, Oct. 10, 2026 (GLOBE NEWSWIRE) -- CGTN published an article on China&#039;s efforts to empower women through digital technologies. Drawing on Peng Liyuan&#039;s remarks at the 2026 UNESCO Prize for Girls&#039; and Women&#039;s Education award ceremony on Friday, the article highlights China&#039;s efforts to advance women&#039;s digital skills, promote gender equality and expand international cooperation to bridge the gender digital divide.</div><div><br></div><div>"At that moment, I realized I had to master this technology," said Saba Aliyeva, a participant from Azerbaijan, after trying AI photo editing for the first time during a training program in Dongguan, south China&#039;s Guangdong Province, in June 2026.</div><div><br></div><div>She was among 51 women from 10 countries who took part in two training programs on AI, digital entrepreneurship and technology empowerment, organized to help women from developing countries build skills for the digital age.</div><div><br></div><div>Their experience reflects China&#039;s ongoing efforts to turn digital technologies into practical opportunities for women, a vision also underscored by Peng Liyuan, wife of Chinese President Xi Jinping and a UNESCO special envoy for the advancement of girls&#039; and women&#039;s education.</div><div><br></div><div>In a video address to the 2026 UNESCO Prize for Girls&#039; and Women&#039;s Education award ceremony on Friday, Peng called on the international community to strengthen vocational education and training for women and expand digital and intelligent education, enabling them to use and benefit from these technologies.</div><div><br></div><div>She noted that China&#039;s use of AI to improve education quality had helped advance gender equality in education and women&#039;s all-round development, offering useful experience for countries in the Global South.</div><div><br></div><div>The demand for such empowerment is substantial. Research by the International Finance Corporation found that greater female participation in e-commerce markets in Africa and Southeast Asia could generate over $300 billion in revenue between 2025 and 2030.</div><div><br></div><div>China is expanding women&#039;s digital skills through national initiatives on digital literacy and rural development, including training programs and support for women-led e-commerce businesses. In 2024, 14,147 women obtained vocational skills certificates as AI trainers, accounting for 42.3% of the annual total. Women also account for more than half of entrepreneurs in China&#039;s internet sector and about one-third of workers in emerging fields such as digital trade, e-commerce and livestreaming.</div><div><br></div><div>China is also sharing its experience internationally. Established in July 2025, the Global Exchange and Cooperation Center for Digital Empowerment of Women reflects the goals outlined by President Xi in a congratulatory letter to the 2024 Shanghai Cooperation Organization Forum on Women, in which he expressed China&#039;s willingness to work with all parties to promote scientific and technological innovation and women&#039;s development through digital empowerment.</div><div><br></div><div>Beyond skills training, China advocates for inclusive digital governance. Through its Global AI Governance Initiative, launched at the third Belt and Road Forum, China called for eliminating gender bias in AI development. Furthermore, China promoted the resolution on "Enhancing International Cooperation on Capacity-building of Artificial Intelligence," adopted at the UN General Assembly, to improve digital inclusion and promote gender equality.</div><div><br></div><div>As Peng said on Friday, education for girls and women sows the seeds of hope, nurtures dreams and reaps happiness. By combining practical skills training with international exchanges and cooperation, China is contributing to efforts to ensure that more women can use digital technologies, participate in the digital economy and benefit from the digital transformation.</div><div><br></div><div>For more information, please click:</div><div>https://news.cgtn.com/news/2026-10-10/How-China-uses-digital-tech-to-empower-women-globally-1R7KuZ2GTMk/p.html</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sun, 11 Oct 2026 07:06:00 +0700</pubDate>
</item>
<item>
<title>ONYX Hospitality Group Marks 60 Years with Curated Partnerships Bringing &quot;More of What You Love&quot; to Life</title>
<link>https://relleaseid.com/berita-bisnis/ONYX-Hospitality-Group-Marks-60-Years-with-Curated-Partnerships-Bringing--quot-More-of-What-You-Love-quot--to-Life</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/9707_ONYX-Hospitality-Group-Marks-60-Years-with-Curated-Partnerships-Bringing--quot-More-of-What-You-Love-quot--to-Life.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Issuer: ONYX Hospitality Group</div><div><br></div><div>BANGKOK, THAILAND - Media OutReach Newswire - 9 October 2026 - ONYX Hospitality Group, a leading hospitality management company in Asia-Pacific specialising in hotels, resorts, serviced apartments and luxury residences, is bringing its 60th anniversary campaign, "More of What You Love," to life through a series of collaborations designed to create new experiences for today&#039;s travellers.</div><div><br></div><div>Bringing together Thai heritage, contemporary creativity and digital connectivity, ONYX Hospitality Group is collaborating with ChaTraMue, Thailand&#039;s iconic tea brand; internationally recognised Thai artist Benzilla; and Grab Thailand, a leading digital platform for mobility and everyday services. Each partnership adds a different dimension to the ONYX experience, spanning food and beverage, art, lifestyle and mobility, while connecting the Group&#039;s Thai roots and hospitality expertise with the way people travel, dine and discover today.</div><div><br></div><div>Two Thai Brands, One Shared Heritage</div><div><br></div><div>ONYX Hospitality Group and ChaTraMue unite two Thai brands with longstanding legacies and generations of consumer recognition. With a tea-making heritage dating back to 1925, ChaTraMue contributes one of Thailand&#039;s most familiar flavours, complemented by ONYX&#039;s expertise in hospitality, dining and experience creation.</div><div><br></div><div>The collaboration will introduce new menus, beverages and guest experiences that give a much-loved part of Thai culture a fresh expression across ONYX hotels and restaurants. From a familiar cup of Thai tea to new interpretations created for different occasions, the partnership invites guests to experience more of a flavour they already know and love.</div><div><br></div><div>OZO Meets the Creative World of Benzilla</div><div><br></div><div>For OZO, Thai artist Benzilla brings the brand&#039;s playful personality to life through a collection of four specially designed luggage stickers, turning the suitcase into a canvas for travel memories. Inspired by OZO&#039;s lively, youthful spirit and interpreted through Benzilla&#039;s bold contemporary style, the collection captures the fun and spontaneity at the heart of the brand. Designed to travel beyond the hotel, the stickers give guests a reminder of their journey while showing how Thai creative talent can translate OZO&#039;s personality into something personal, expressive and shareable.</div><div><br></div><div>Connecting Travel and Discovery with Grab Thailand</div><div><br></div><div>ONYX Hospitality Group&#039;s collaboration with Grab Thailand brings hospitality and digital convenience closer together, connecting Grab&#039;s ecosystem and consumer reach with ONYX hotels, restaurants and lifestyle experiences. By integrating transport, dining and destination discovery, the partnership helps make the guest journey more seamless while allowing travellers to engage with ONYX through a platform already part of their everyday lives.</div><div><br></div><div> It also creates new opportunities for the Group to reach digitally active consumers before, during and beyond their stay, making its brands, dining and destinations easier to access and enjoy.</div><div><br></div><div>Different Strengths, More to Experience</div><div><br></div><div>While each initiative is distinct, they share a common idea: combining ONYX&#039;s hospitality expertise with the strengths of each partner to create meaningful value for today&#039;s guests.</div><div><br></div><div>Pornthip Paothong, Vice President, Brand and Marketing, ONYX Hospitality Group said: "Our 60th anniversary celebrates our Thai roots and the hospitality experience we have built over the past six decades, while also looking at what guests value today. &#039More of What You Love&#039 is about giving people more reasons to enjoy their time with us - from the hotels they stay in and the food they discover to the destinations they explore. Together, they allow us to create experiences that reflect how people live and travel today."</div><div><br></div><div>The collaborations form part of ONYX Hospitality Group&#039;s wider 60th anniversary campaign, creating new reasons for guests to engage with and return to its brands. Across Amari, OZO, Shama and Oriental Residence, ONYX Hospitality Group continues to develop experiences shaped around the distinct character of each brand, supported by its deep understanding of hospitality and destinations across Asia-Pacific.</div><div><br></div><div>As ONYX enters its seventh decade, the Group will continue to explore partnerships that connects its heritage with creativity and contemporary lifestyles, with further anniversary initiatives to be introduced throughout the year.</div><div><br></div><div>Hashtag: #ONYXHospitalityGroup</div><div><br></div><div>About ONYX Hospitality Group:</div><div>ONYX Hospitality Group is a leading hospitality management company in Asia-Pacific, with a complementary portfolio of brands comprising Amari, OZO, Shama and Oriental Residence. Together, these brands serve the diverse needs of business and leisure travellers across the region, where ONYX has deep market expertise.</div><div><br></div><div> Beyond accommodation, the Group also operates spa and food and beverage businesses. Drawing on six decades of management experience, ONYX delivers innovative hospitality solutions across the region while upholding internationally recognised standards and maintaining operational agility. By building enduring relationships with like-minded business partners, ONYX Hospitality Group delivers distinctive experiences in a dynamic and competitive market, responding to the evolving needs of today&#039;s travellers.</div><div><br></div><div>More information: www.onyx-hospitality.com</div><div><br></div><div>Find us on social media:</div><div>Follow us on Instagram: https://www.instagram.com/onyxhospitalitygroup/</div><div>Follow us on LinkedIn: https://www.linkedin.com/company/onyx-hospitality-group/</div><div>Follow us on Facebook: https://www.facebook.com/ONYXHospitalityGroup</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div>   ]]></description>
<pubDate>Sun, 11 Oct 2026 07:00:00 +0700</pubDate>
</item>
<item>
<title>Big Apple Donuts &amp; Coffee Opens Its 100th Store in Malaysia, Celebrates With RM1 Pandan Donuts Nationwide</title>
<link>https://relleaseid.com/berita-bisnis/Big-Apple-Donuts--amp--Coffee-Opens-Its-100th-Store-in-Malaysia--Celebrates-With-RM1-Pandan-Donuts-Nationwide</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/5202_Big-Apple-Donuts--amp--Coffee-Opens-Its-100th-Store-in-Malaysia--Celebrates-With-RM1-Pandan-Donuts-Nationwide.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Issuer: Big Apple Donuts & Coffee</div><div><br></div><div>Born and grown in Malaysia, the 19-year-old brand marks the milestone at IOI Mall Puchong and welcomes new franchise partners</div><div>PUCHONG, MALAYSIA - Media OutReach Newswire - 10 October 2026 - Big Apple Donuts & Coffee, the donut and coffee brand born and grown in Malaysia, today opened its 100th store in Malaysia at IOI Mall Puchong, marking a major milestone in its 19-year journey.</div><div><br></div><div>Left to right: Mr. Mohammad Fadzli B. Zainurdin, General Manager, Big Apple Donuts & Coffee; Mr. Takashi Horii, Chief Financial Officer, Big Apple Donuts & Coffee; Mr. Yasuo Mizoguchi, Managing Director, Big Apple Donuts & Coffee; Mr. Ron Poon, Director, Big Apple Donuts & Coffee; Mr. Nilamegan, Operations Manager, IOI Mall Puchong; and Mr. Edward Yong, Senior Manager, FO Design, at the opening of Big Apple Donuts & Coffee&#039;s 100th store in Malaysia at IOI Mall Puchong on 10 October 2026.</div><div><br></div><div>Left to right: Mr. Mohammad Fadzli B. Zainurdin, General Manager, Big Apple Donuts & Coffee; Mr. Takashi Horii, Chief Financial Officer, Big Apple Donuts & Coffee; Mr. Yasuo Mizoguchi, Managing Director, Big Apple Donuts & Coffee; Mr. Ron Poon, Director, Big Apple Donuts & Coffee; Mr. Nilamegan, Operations Manager, IOI Mall Puchong; and Mr. Edward Yong, Senior Manager, FO Design, at the opening of Big Apple Donuts & Coffee&#039;s 100th store in Malaysia at IOI Mall Puchong on 10 October 2026.</div><div><br></div><div>The official announcement took place at 1.00pm, and the new store at EFK-03, 1st Floor, South Court, IOI Mall Puchong, 47170 Puchong, Selangor opened to the public the same day.</div><div><br></div><div>To celebrate, Big Apple is offering its two pandan donuts, Ola Pandan and Dreamy Pandan, at RM1 each at all outlets nationwide until 31 October 2026, while stocks last. Each store offers 100 pieces a day, with no limit per customer. The offer is for in-store purchases only and is not available on delivery apps.</div><div><br></div><div>"Big Apple was born in Malaysia 19 years ago, and every one of our 100 stores was built on the support of Malaysian customers, our team and our franchise partners. This milestone belongs to them, and we are deeply grateful," said Mr. Yasuo Mizoguchi, Managing Director of Big Apple Donuts & Coffee.</div><div><br></div><div>Big Apple opened its first store at The Curve, Mutiara Damansara, Petaling Jaya, in 2007, and will celebrate its 20th anniversary in 2027.</div><div><br></div><div>"We wanted to say thank you in a way every Malaysian can enjoy. Pandan is a flavour close to Malaysian hearts, so for the rest of October, Ola Pandan and Dreamy Pandan are RM1 at every outlet," he said.</div><div><br></div><div>Ola Pandan has a fragrant pandan glaze topped with a creamy vanilla swirl. Dreamy Pandan has a sweet pandan glaze with a dreamy, creamy vanilla topping and drizzle.</div><div><br></div><div>Big Apple&#039;s network in Malaysia includes both company-owned and franchised stores, and the brand welcomes new franchise partners.</div><div><br></div><div>"The F&B scene keeps changing, and customers have more choice than ever. To stay relevant, we keep listening to them. One hundred stores is a milestone, not a finish line. We will continue to grow and evolve into a brand that is loved by more customers and brings even greater happiness to their everyday lives," he added.</div><div><br></div><div>"Looking ahead to 2027, we plan to open another 10 stores across Malaysia as part of our continued expansion. Our ambition is to strengthen our presence nationwide and work towards becoming the number one donut brand in Malaysia," he said.</div><div><br></div><div>Big Apple Donuts & Coffee products are halal-certified. More information is available at https://www.bigappledonuts.com/big-apple-donuts-100th-store-malaysia/</div><div><br></div><div>Key facts</div><div><br></div><div>Milestone: 100th Big Apple Donuts & Coffee store in Malaysia</div><div>Opened: Saturday, 10 October 2026, at IOI Mall Puchong, Selangor</div><div>Offer: Ola Pandan and Dreamy Pandan at RM1 each, all outlets nationwide, until 31 October 2026, while stocks last (100 pieces per store per day, in-store only)</div><div>Heritage: first store opened in 2007 at The Curve, Mutiara Damansara</div><div>Franchise: Big Apple welcomes new franchise partners</div><div>2027 plans: another 10 stores across Malaysia</div><div><br></div><div>https://www.bigappledonuts.com</div><div>https://www.linkedin.com/company/big-apple-donuts-coffee</div><div>https://twitter.com/BigAppleDnC</div><div>https://www.facebook.com/bigappledonutscoffee/</div><div>https://www.instagram.com/bigappledonutscoffee/</div><div>https://www.tiktok.com/@bigappledonutsandcoffee</div><div>https://youtube.com/@bigappledonutscoffee</div><div>Hashtag: #BigAppleDonuts #OneSweetMilestone #BigApple100 #Donuts #Malaysia #FnB</div><div><br></div><div><span style="font-size: 14px;">About Big Apple Donuts & Coffee</span></div><div>Big Apple Donuts & Coffee is a donut and coffee brand born and grown in Malaysia. Since opening its first store at The Curve, Mutiara Damansara, in 2007, the brand has grown to 100 stores in Malaysia and 10 in Cambodia, serving freshly made donuts and coffee for 19 years. Its products are halal-certified, and the brand welcomes new franchise partners. For store locations, visit <a href="http://www.bigappledonuts.com.">www.bigappledonuts.com.</a></div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div>   ]]></description>
<pubDate>Sun, 11 Oct 2026 06:53:00 +0700</pubDate>
</item>
<item>
<title>Arla Foods Ingredients memamerkan inovasi minuman clear shake (protein bening) yang dipersonalisasi di SupplySide Global</title>
<link>https://relleaseid.com/berita-bisnis/Arla-Foods-Ingredients-memamerkan-inovasi-minuman-clear-shake--protein-bening--yang-dipersonalisasi-di-SupplySide-Global</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/1897_Arla-Foods-Ingredients-memamerkan-inovasi-minuman-clear-shake--protein-bening--yang-dipersonalisasi-di-SupplySide-Global.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>KOPENHAGEN, Denmark, Oct. 10, 2026 (GLOBE NEWSWIRE) -- Arla Foods Ingredients akan memperkenalkan tiga solusi baru minuman clear shake yang dipersonalisasi dan menawarkan beragam manfaat dalam ajang SupplySide Global yang berlangsung pada tanggal (28-30 Oktober di Las Vegas).</div><div><br></div><div>Konsep-konsep ini menunjukkan bagaimana berbagai merek dapat beralih dari pendekatan minuman protein yang seragam untuk semua konsumen menuju pengembangan solusi protein yang disesuaikan dengan beragam kebutuhan terkait performa dan gaya hidup aktif.&nbsp;</div><div><br></div><div>Konsep-konsep ini menjawab meningkatnya permintaan pasar terhadap minuman protein bening sebagai alternatif yang lebih ringan, bercita rasa buah, dan lebih menyegarkan dibandingkan minuman protein konvensional berbasis susu.&nbsp;&nbsp;</div><div><br></div><div>Ketiga konsep ini memadukan protein whey Lacprodan berkualitas tinggi dengan bahan-bahan fungsional pilihan, serta dirancang untuk memenuhi kebutuhan pemulihan yang sama sekaligus memberikan tiga manfaat performa yang berbeda:&nbsp;</div><div><br></div><div>BUILD: Minuman Protein untuk Latihan Resistensi dengan Lacprodan ISO.RefreshShake + kreatin, yang diformulasikan khusus untuk aktivitas yang berfokus pada kekuatan dan tenaga, seperti angkat beban, latihan kekuatan, dan CrossFit.&nbsp;</div><div>SUSTAIN: Minuman Protein untuk Daya Tahan dengan Lacprodan Pro2O + karbohidrat dan elektrolit, yang diformulasikan khusus untuk aktivitas yang berfokus pada daya tahan, seperti lari, bersepeda, dan olahraga daya tahan.&nbsp;</div><div>MOVE: Minuman Protein untuk Mobilitas dengan Lacprodan ISO.WaterShake + kolagen untuk aktivitas yang berfokus pada mobilitas, seperti yoga, pilates, senam, dan tari.&nbsp;</div><div><br></div><div>Peter Schouw Andersen, Direktur Senior Nutrisi Performa di Arla Foods Ingredients, mengatakan: "Konsep-konsep baru minuman clear shake yang dipersonalisasi ini menunjukkan bagaimana isolat protein whey bening kami membantu berbagai merek mengembangkan produk bercita rasa lezat yang sesuai dengan beragam kebutuhan konsumen dan tujuan peningkatan performa. Konsep-konsep ini dirancang untuk beragam pengguna produk nutrisi olahraga dengan menawarkan protein berkualitas tinggi dan manfaat fungsional dalam format yang praktis. Mulai dari kekuatan dan tenaga hingga daya tahan dan hidrasi, serta mobilitas dan fleksibilitas, konsep-konsep ini menunjukkan fleksibilitas protein whey bening sebagai dasar pengembangan produk nutrisi olahraga yang dipersonalisasi."&nbsp;&nbsp;</div><div><br></div><div>Pengunjung SupplySide Global dapat mencicipi berbagai solusi minuman shake yang dipersonalisasi di Stan #2945, bersama dengan:&nbsp;</div><div><br></div><div>Protein bar susu berpori dengan tekstur ringan yang menghadirkan pengalaman sensori baru dalam menikmati protein bar. Memadukan nutrisi dan kenikmatan dalam setiap gigitan yang ringan, AirBar menggunakan Nutrilac PB-8420 yang menghasilkan struktur berpori yang stabil dan menjaga kestabilan tekstur.&nbsp;</div><div><br></div><div>Minuman berbasis air berprotein tinggi dalam porsi kecil sebagai nutrisi pendamping GLP-1, yang dirancang dalam kemasan ringkas untuk konsumen dengan nafsu makan menurun. Produk yang mengandung Lacprodan BLG-100 ini memiliki kandungan protein 21 g per 100 ml, bebas lemak dan gula, serta rendah laktosa. Produk ini juga menawarkan cita rasa lezat, rasa sepat yang minimal, dan stabilitas selama penyimpanan pada suhu ruang.&nbsp;</div><div><br></div><div>Minuman soda protein berkarbonasi dengan cita rasa buah yang memadukan daya tarik khas minuman ringan dengan isolat protein whey berkualitas tinggi. Produk ini dibuat menggunakan Lacprodan Pro2O, yang memungkinkan pengembangan minuman soda protein bening dengan kekentalan rendah, cita rasa yang bersih, rasa sepat yang minimal, dan cita rasa yang kuat. Bahan ini mendukung pengembangan minuman ringan fungsional bercita rasa buah yang stabil dan diperkaya dengan protein.&nbsp;</div><div><br></div><div>Untuk informasi lebih lanjut mengenai konsep minuman clear shake yang dipersonalisasi dari Arla Foods Ingredients, kunjungi: https://www.arlafoodsingredients.com/personalised-clearshakes/&nbsp;&nbsp;</div><div><br></div><div>hz@ispiderpr.com</div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 12:16:00 +0700</pubDate>
</item>
<item>
<title>OPPO Find X10 Pro Max to Debut Globally with MediaTek&#039;s 2nm Flagship Dimensity 9600 Pro</title>
<link>https://relleaseid.com/berita-bisnis/OPPO-Find-X10-Pro-Max-to-Debut-Globally-with-MediaTek--039-s-2nm-Flagship-Dimensity-9600-Pro</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/6407_OPPO-Find-X10-Pro-Max-to-Debut-Globally-with-MediaTek--039-s-2nm-Flagship-Dimensity-9600-Pro.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div><br></div><div>SHENZHEN, CHINA - Media OutReach Newswire - 9 October 2026 - OPPO, a leading global smart device brand, today announced that the upcoming Find X10 Pro Max will be among the first smartphones to feature the flagship MediaTek Dimensity 9600 Pro and launch in international markets.</div><div><br></div><div>Built on TSMC&#039;s advanced 2nm N2P process, the MediaTek Dimensity 9600 Pro delivers a significant generational leap in performance and power efficiency. Compared with the previous-generation process, it delivers up to a 61% improvement in CPU multi-core energy efficiency, providing a stronger foundation for sustained flagship performance and increasingly demanded on-device AI workloads on Find X10 Pro Max.</div><div><br></div><div>For CPU performance, the Dimensity 9600 Pro continues MediaTek&#039;s All-Big-Core architecture with a new configuration featuring two 4.55GHz C2-Ultra cores and six performance cores. The new CPU delivers an overall performance improvement of 17%, while independent frequency control for each core enables more precise workload scheduling, helping Find X10 Pro Max balance sustained performance with outstanding power efficiency.</div><div><br></div><div>Graphics performance takes another step forward with the latest flagship G2-Ultra NX GPU, introducing enhanced ray tracing and new neural graphics capabilities. Under sustained heavy workloads, the Dimensity 9600 Pro delivers approximately 27% higher performance, enabling richer visual detail and more immersive gaming experiences on Find X10 Pro Max.</div><div><br></div><div>The Dimensity 9600 Pro also brings a major upgrade to on-device AI with its latest-generation dual-NPU design, combining a powerful NPU with a Super Efficient NPU. The new high-performance NPU delivers 51% faster LLM prefill performance, providing powerful support for workloads including large-model inference and computational imaging. Meanwhile, the Super Efficient NPU is 40% more power efficient, enabling persistent AI capabilities to run at ultra-low power for more responsive and always-available AI experiences.</div><div><br></div><div>Further enhancing the platform is OPPO Laminar Flow Engine, jointly developed by OPPO and MediaTek and making its debut on Find X10 Pro Max. By restructuring the underlying rendering architecture and coordinating it more closely with system scheduling, the technology achieves a better balance between ultra-smooth system responsiveness and low power consumption. It also helps accelerate app launches and maintain smooth and stable content loading during demanding scenarios such as rapid photo browsing.</div><div><br></div><div>Further details about OPPO Find X10 Pro Max, powered by the MediaTek Dimensity 9600 Pro, will be revealed at the upcoming global launch event.</div><div><br></div><div>About OPPO</div><div><br></div><div>OPPO is a leading global smart device brand. Since the launch of its first mobile phone - "Smiley Face" - in 2008, OPPO has been in relentless pursuit of the perfect synergy of aesthetic satisfaction and innovative technology. </div><div><br></div><div>Today, OPPO provides a wide range of smart devices spearheaded by the Find and Reno series. Beyond devices, OPPO also provides its users with ColorOS operating system and internet services. OPPO has footprints in more than 90 countries and regions, with more than 40,000 employees dedicated to creating a better life for customers around the world.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #OPPO</div><div><br></div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 12:11:00 +0700</pubDate>
</item>
<item>
<title>VOLUNTARY TOTALITARIAN TENDER OFFER FOR ALL OF THE COMMON SHARES OF IVECO GROUP N.V. INCREASE IN THE PRICE OF THE OFFER TO EURO 14.40 PER COMMON SHARE</title>
<link>https://relleaseid.com/berita-bisnis/VOLUNTARY-TOTALITARIAN-TENDER-OFFER-FOR-ALL-OF-THE-COMMON-SHARES-OF-IVECO-GROUP-N-V--INCREASE-IN-THE-PRICE-OF-THE-OFFER-TO-EURO-14-40-PER-COMMON-SHARE</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/1336_VOLUNTARY-TOTALITARIAN-TENDER-OFFER-FOR-ALL-OF-THE-COMMON-SHARES-OF-IVECO-GROUP-N-V--INCREASE-IN-THE-PRICE-OF-THE-OFFER-TO-EURO-14-40-PER-COMMON-SHARE.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION</div><div><br></div><div>VOLUNTARY TOTALITARIAN TENDER OFFER FOR ALL OF THE COMMON SHARES OF IVECO GROUP N.V.</div><div><br></div><div>* * *</div><div><br></div><div>PRESS RELEASE</div><div><br></div><div>pursuant to Articles 36 and 43 of the Resolution no. 11971 of 14 May 1999, as further amended and supplemented (the "Issuers&#039; Regulation")</div><div><br></div><div>INCREASE IN THE PRICE OF THE OFFER TO EURO 14.40 PER COMMON SHARE</div><div><br></div><div>OFFEROR DECLARES NEW PRICE AS BEST AND FINAL</div><div><br></div><div>* * * * *</div><div><br></div><div>Amsterdam, the Netherlands, 9 October 2026 ? With reference to the voluntary totalitarian tender offer (the "Offer") promoted by TML CV Holdings Pte. Ltd. ("TML CV HS"), through the wholly-owned company TML CV Holdings B.V. (the "Offeror"), under Articles 102 et seq. of the Italian Legislative Decree no. 58 of 24 February 1998, as further amended and supplemented (the "CFA"), on all the common shares (the "Common Shares") of Iveco Group N.V. ("IVG" or the "Issuer"), the acceptance period of which commenced on 7 September 2026, the Offeror hereby announces the following pursuant to Articles 36 and 43 of the Issuers&#039; Regulation.</div><div><br></div><div>Capitalised terms used in this press release, unless otherwise defined, shall have the meanings ascribed to them in the offer document relating to the Offer, approved by CONSOB by resolution No. 24119 of 3 September 2026 and published on 4 September 2026 (the "Offer Document").</div><div><br></div><div>The Offeror hereby announces, pursuant to Article 43, paragraph 1, of the Issuers&#039; Regulation, that it has increased the Price of the Offer from Euro 14.10 (cum dividend) to Euro 14.40 (cum dividend) for each Common Share tendered to the Offer (the "New Price"), providing for a cash increase of Euro 0.30 (the "Additional Price").</div><div><br></div><div>The Offeror considers that the previous Price already represented a full and fair valuation of the Issuer. Nevertheless, the Offeror has resolved to increase the Price in consideration of the slight delay in the completion of the Offer, due to Prior Authorisations process taking longer than initially anticipated in a few jurisdictions.</div><div><br></div><div>The Offeror hereby specifies that the New Price is its best and final determination of the consideration under the Offer and will not be increased further.</div><div><br></div><div>The New Price is intended to be cum dividend (and, therefore, inclusive of coupons relating to any dividends distributed by the Issuer) and has, therefore, been determined on the assumption that the Issuer will not approve and/or will not make any ordinary and extraordinary distribution of dividends from profits or reserves before the Payment Date and/or the Payment Date upon Completion of the Reopening of the Terms, if applicable.</div><div><br></div><div>The New Price represents, inter alia:</div><div><br></div><div>(i)&nbsp; &nbsp; &nbsp;a premium equal to 6.77% with respect to the official price of the Common Shares recorded on 29 July 2025 (i.e., the last Trading Day preceding the Announcement Date);</div><div><br></div><div>(ii)&nbsp; &nbsp; &nbsp;a premium equal to 33.47% with respect to the official price of the Common Shares recorded on 17 July 2025 (i.e., the Trading Day immediately preceding the publication of the rumours regarding a potential acquisition of IVG by Tata Motors) (the "Undisturbed Date");</div><div><br></div><div>(iii)&nbsp; &nbsp; &nbsp;premiums equal to 26.87%, 27.57%, 38.23% and 67.98% with respect to the volume-weighted arithmetic averages of the official prices of the Common Shares for 1 (one), 3 (three), 6 (six) and 12 (twelve) months preceding the Undisturbed Date (included), respectively.</div><div><br></div><div>In the event of full acceptance of the Offer, i.e., in the event that all no. 271,215,400 Common Shares are tendered to the Offer, the Maximum Aggregate Disbursement is increased of Euro 81,364,620.00 (the "Additional Maximum Aggregate Disbursement") for an overall maximum aggregate amount to be paid under the Offer, calculated on the basis of the New Price, equal to Euro 3,905,501,760.00 (the "New Maximum Aggregate Disbursement").</div><div><br></div><div>It should be noted that, on the date hereof, the Offeror (i) entered into a credit facility agreement with MUFG Bank Ltd., GIFT Branch, as lender, for a total commitment amount equal to Euro 85,000,000.00 aimed, among other things, at funding the payment of the Additional Price to the tendering shareholders up to the Additional Maximum Aggregate Disbursement, and (ii) submitted to CONSOB, pursuant to Article 37-bis of the Issuers&#039; Regulation, the documentation evidencing the issuance of a new guarantee of exact fulfilment of the obligation to pay the Additional Price of the Offer up to the Additional Maximum Aggregate Disbursement, issued by MUFG Bank Ltd., GIFT Branch, which is in addition to, and does not replace, the Guarantee of Exact Fulfilment issued on 3 September 2026.</div><div><br></div><div>Below are set out the tables contained in Paragraphs E.2.2, E.4 and E.5 of the Offer Document, updated to reflect the New Price.</div><div><br></div><div>* * * * *</div><div><br></div><div>Paragraph E.2.2 of the Offer Document "Weighted averages in different time intervals prior to the Reference Date and the Undisturbed Date"</div><div><br></div><div>The following table compares the New Price (equal to Euro 14.40 per Common Share) with volume weighted averages of the official prices of the Common Shares recorded on each of the previous 1 (one), 3 (three), 6 (six) and 12 (twelve) months prior to the Undisturbed Date (included).</div><div><br></div><div><table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Reference period<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;mso-border-left-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Volume weighted average official
  prices (in Euro)<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;mso-border-left-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Difference between the New Price
  and the VWAP of IVG Shares (Euro)<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;mso-border-left-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Implied Premium of the New Price
  (%)<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">17 July 2025<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">10.79<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.61<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">33.47%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">1-month price average<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">11.35<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.05<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">26.87%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">3-month price average<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">11.29<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.11<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">27.57%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">6-month price average<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">10.42<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.98<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">38.23%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">12-month price average<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.57<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.83<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">67.98%<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Source: Euronext.<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">For completeness, the
following table compares the New Price with volume weighted averages of the
official prices of the Common Shares recorded on each of the previous 1 (one),
3 (three), 6 (six) and 12 (twelve) months prior to the Trading Day preceding the
Announcement Date (included).<o:p></o:p></p>

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Reference
  period<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;mso-border-left-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Volume
  weighted average official prices (in Euro)<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;mso-border-left-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Difference
  between the New Price and the VWAP of IVG Shares (Euro)<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;mso-border-left-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Implied
  Premium of the New Price (%)<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">29
  July 2025<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">13.49<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.91<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.77%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1-month
  price average<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">12.14<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.26<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">18.61%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3-month
  price average<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">11.75<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.65<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">22.53%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6-month
  price average<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">10.91<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.49<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">32.00%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">12-month
  price average<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.92<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.48<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;mso-border-top-alt:solid black 1.0pt;
  mso-border-left-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">61.47%<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Source: Euronext.<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Paragraph E.4 of the
Offer Document "Comparison of the Price with some indicators related to
the Issuer"<o:p></o:p></p>

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border-top:solid black 1.0pt;border-left:none;
  border-bottom:solid black 1.0pt;border-right:none;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Price multiples1<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:solid black 1.0pt;border-left:none;
  border-bottom:solid black 1.0pt;border-right:none;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">31
  December 2025<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:solid black 1.0pt;border-left:none;
  border-bottom:solid black 1.0pt;border-right:none;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">31
  December 2024<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:solid black 1.0pt;border-left:none;
  border-bottom:solid black 1.0pt;border-right:none;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">31
  December 2023<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">EV/Revenues2<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">0.5x<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">0.5x<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">0.4x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">EV/EBITDA2<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">4.5x<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">4.0x<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">4.1x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">EV/EBIT2<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">12.4x<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">8.7x<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">8.4x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">P/E<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">16.7x<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">8.0x<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">16.4x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">P/Cash Flow3<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">21.4x<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">8.6x<o:p></o:p></p>
  </td>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">6.6x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">P/Book Value<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">2.3x<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">2.3x<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">2.8x<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Source: Issuer&#039;s
available published audited financial reports as at 31 December 2025, 31
December 2024 and 31 December 2023.<br>
1&nbsp;Enterprise value bridge reflects industrial net
cash, industrial underfunded pensions, industrial other provisions, and
industrial minority interest and investments as of 31 March 2025.<br>
2&nbsp;For the purposes of the above table, EV has been
calculated based on the financial results as at 31 March 2025.<br>
3&nbsp;Cash Flow defined as NOPAT + D&A ? Change in
NWC ? Capex.<o:p></o:p></p>

<div align="center">

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Company<o:p></o:p></p>
  </td>
  <td colspan="3" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">EV/Revenues<o:p></o:p></p>
  </td>
  <td colspan="3" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">EV/EBITDA<o:p></o:p></p>
  </td>
  <td colspan="3" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">EV/EBIT<o:p></o:p></p>
  </td>
  <td colspan="3" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">P/E<o:p></o:p></p>
  </td>
  <td colspan="3" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">P/Cash
  Flow<o:p></o:p></p>
  </td>
  <td colspan="3" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">P/Book
  Value<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td style="border:none;border-bottom:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">&nbsp;<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2023<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2023<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2023<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2023<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2023<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2023<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Daimler<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.2x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">18.0x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">11.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">10.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">13.9x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.7x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">PACCAR<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.2x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">12.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">7.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">14.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">7.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">20.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">11.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">10.9x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">30.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">17.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">16.0x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.6x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Traton<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.9x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.2x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">9.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.0x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.5x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td style="border:none;border-bottom:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Volvo<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.0x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">1.0x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">7.9x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">10.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.2x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">16.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">11.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">11.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">26.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">13.2x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">16.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">3.6x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td style="border:none;border-bottom:solid black 1.0pt;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Average<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">7.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.9x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">9.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">16.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">9.9x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">9.2x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">18.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">10.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">13.0x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.8x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td style="border:none;border-bottom:solid black 1.0pt;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">Median<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">5.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.8x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">17.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">11.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">9.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">18.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">10.9x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">14.9x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.6x<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td style="border:none;border-bottom:solid black 1.0pt;mso-border-top-alt:
  solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">IVG4<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">0.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.5x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.0x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">4.1x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">12.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">16.7x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.0x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">16.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">21.4x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">8.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">6.6x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.3x<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;border-bottom:solid black 1.0pt;
  mso-border-top-alt:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal">2.8x<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

</div>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Sources: Issuer and
other company filings and public information; Capital IQ.<br>
4&nbsp;Reflects enterprise value, revenue, EBITDA, EBIT, Net
Profit, Cash Flow, and Book Value of industrials business.<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Paragraph E.5 of the
Offer Document "Arithmetic weighted monthly average of official
registered prices of the Issuer&#039;s shares in the last 12 months prior to the
launch of the Offer"<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">The following table
provides a comparison between the Price and the arithmetic weighted averages
for daily volumes of the official prices of the Issuer&#039;s shares on Euronext
Milan, registered in each of the 12 months up to the Announcement Date
(included).<o:p></o:p></p>

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Period<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">Total
  volumes<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">Exchange
  values<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">Weighted
  average price<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-top:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">Premium
  implicit of the New Price<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">&nbsp;<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">thousands<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">?
  thousands<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">?<o:p></o:p></p>
  </td>
  <td valign="top" style="border:none;border-bottom:solid black 1.0pt;padding:
  .75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">1-30 July 2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">116,786<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">1,430,684<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">12.25<o:p></o:p></p>
  </td>
  <td valign="bottom" style="border:none;mso-border-top-alt:solid black 1.0pt;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">17.55%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">June 2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">51,442<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">594,766<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">11.56<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">24.55%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">May 2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">77,772<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">888,032<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">11.42<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">26.11%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">April 2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">63,854<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">608,064<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">9.52<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">51.22%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">March 2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">77,773<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">876,512<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">11.27<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">27.77%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">February 2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">109,277<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">1,099,080<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">10.06<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">43.17%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">January 2025<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">122,428<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">891,437<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">7.28<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">97.77%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">December 2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">56,915<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">387,095<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">6.80<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">111.73%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">November 2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">77,046<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">519,002<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">6.74<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">113.77%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">October 2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">85,321<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">564,603<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">6.62<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">117.61%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">September 2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">67,675<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">428,964<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">6.34<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">127.18%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">August 2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">57,117<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">358,596<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">6.28<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">129.36%<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">31 July 2024<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">5,327<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">35,675<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">6.70<o:p></o:p></p>
  </td>
  <td valign="bottom" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="right" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:right;line-height:normal">115.04%<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><br></p><p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Source: Euronext.</p></div><div>This press release should be read together with the Offer Document prepared by the Offeror, both available to the public at:</div><div><br></div><div>the registered office of the Offeror at Basisweg 10, 1043AP Amsterdam, The Netherlands;</div><div>the registered office of the Issuer at Via Puglia 35, 10156 Turin, Italy;</div><div>the registered office of BNP Paribas, Italian Branch, as intermediary responsible for coordinating the collection of the acceptances, at Piazza Lina Bo Bardi 3, 20124 Milan, Italy;</div><div>the website of Tata Motors at https://cv.tatamotors.com/;</div><div>the website of the Issuer at https://www.ivecogroup.com/; and</div><div>the website of the Georgeson S.r.l., as global information agent, at www.georgeson.com/it.</div><div>Except as indicated in this press release with reference to the New Price, all other terms and conditions of the Offer indicated in the Offer Document remain unaffected.</div><div><br></div><div>The Offeror will also publish an Acceptance Form amended to reflect the New Price as set out in this press release. For the avoidance of doubt, execution of the previous version of the Acceptance Form will be deemed a valid acceptance of the Offer on the improved terms set out in this press release. Accordingly, no further action is required from shareholders who have already tendered their Common Shares to the Offer using the previous version of the Acceptance Form.</div><div><br></div><div>Finally, shareholders of the Issuer are reminded that, for any request or information concerning the Offer, they may use the following information channels made available by the Global Information Agent: the e-mail address opa-iveco@georgeson.com, the toll-free number 800 189040 (for callers from Italy), and a direct number +39 06 45229395 (for callers from abroad). These telephone numbers will be active for the entire duration of the Acceptance Period (including any possible extension under the applicable law as well as the Reopening of the Terms, if applicable), on weekdays, from 9:00 a.m. (CE(S)T) to 6:00 p.m. (CE(S)T).</div><div><br></div><div>* * *</div><div><br></div><div>The voluntary totalitarian tender offer referred to in this press release (the "Offer") is promoted by TML CV Holdings Pte. Ltd. ("TML CV HS"), through TML CV Holdings B.V., a company wholly-owned by TML CV HS (the "Offeror") on all issued common shares (the "Common Shares") of Iveco Group N.V. ("IVG" or the "Issuer"). This press release does not constitute either a purchase offer or a solicitation to sell the Common Shares of IVG.</div><div><br></div><div>The Offeror has published an offer document (the "Offer Document"), which IVG&#039;s shareholders must carefully review. The Offer is addressed, on equal conditions, to all the holders of the Common Shares and will be launched in Italy and extended to the United States of America in compliance with Section 14(e) and Regulation 14E of the U.S. Securities Exchange Act of 1934 (the "U.S. Securities Exchange Act"), subject to the applicable exemptions set forth in Rule 14d-1(d) of the U.S. Securities Exchange Act. Except as indicated below, the Offer is subject to disclosure obligations and procedural requirements provided for by Italian law. US IVG shareholders should be aware that such requirements may differ materially from those applicable under US domestic tender offer law and practice.</div><div><br></div><div>In accordance with the laws of, and practice in, Italy and to the extent permitted by applicable law, including Rule 14e-5 under the U.S. Exchange Act, the Offeror, the Offeror&#039;s affiliates or any nominees or brokers of the foregoing (acting as agents, or in a similar capacity, for IVG or any of its affiliates, as applicable) may from time to time, and other than pursuant to the Offer, directly or indirectly, purchase, or arrange to purchase, outside of the United States of America, Common Shares in IVG or any securities that are convertible into, exchangeable for or exercisable for such Common Shares in IVG before or during the period in which the Offer remains open for acceptance. These purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. To the extent information about such purchases or arrangements to purchase is made public in Italy, such information will be disclosed by means of a press release or other means reasonably calculated to inform US shareholders of IVG of such information. In addition, subject to the applicable laws of Italy and US securities laws, including Rule 14e-5 under the U.S. Exchange Act, the financial advisers to the Offeror or their respective affiliates may also engage in ordinary course trading activities in securities of IVG, which may include purchases or arrangements to purchase such securities.</div><div><br></div><div>In order to comply with the rules and exemptions provided by US law, an Offer Document translated into English is being made available to the holders of the Common Shares resident in the United States of America. The English version of the Offer Document is merely a courtesy translation and the Italian version of the Offer Document will be the only document submitted to Consob for its approval.</div><div><br></div><div>It may not be possible for US shareholders to effect service of process within the United States of America upon IVG, the Offeror or any of their respective affiliates, or their respective officers or directors, some or all of which may reside outside the United States of America, or to enforce against any of them judgments of the United States of America courts predicated upon the civil liability provisions of the federal securities laws of the United States of America or other US law. It may not be possible to bring an action against IVG, the Offeror and/or their respective officers or directors (as applicable) in a non-US court for violations of US laws. Further, it may not be possible to compel the Offeror or IVG or their respective affiliates, as applicable, to subject themselves to the judgment of a US court. In addition, it may be difficult to enforce outside the United States of America original actions, or actions for the enforcement of judgments of US courts, based on the civil liability provisions of the US federal securities laws.</div><div><br></div><div>The Offer, if completed, may have consequences under US federal income tax and under applicable U.S. state and local, as well as non-U.S., tax laws. Each shareholder of IVG is urged to consult its independent professional adviser immediately regarding the tax consequences of the Offer.</div><div><br></div><div>NEITHER THE U.S. SECURITIES AND EXCHANGE COMMISSION NOR ANY SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY IN ANY STATE OF THE U.S. HAS APPROVED OR DECLINED TO APPROVE THE OFFER OR THIS ANNOUNCEMENT, PASSED UPON THE FAIRNESS OR MERITS OF THE OFFER OR PROVIDED AN OPINION AS TO THE ACCURACY OR COMPLETENESS OF THIS ANNOUNCEMENT OR ANY OFFER DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENCE IN THE UNITED STATES.</div><div><br></div><div>The Offer has not been and will not be launched or promoted by the Offeror in Canada, Japan, Australia or in any other country other than Italy and the United States of America in which such Offer is not permitted in absence of the authorisation of the competent authorities or other obligations from the Offeror (such countries, including Canada, Japan and Australia, jointly, the "Other Countries"), nor by using instruments of communication or national or international commerce of the Other Countries (including but not limited to the postal network, fax, telex, email, telephone and internet), nor by way of any structure of any of the financial intermediaries of the Other Countries nor in any other way.</div><div><br></div><div>Copy of this press release, or portions of the same, as also copy of any subsequent document which will be issued in connection with the Offer, are not and must not be sent, nor in any way transmitted or distributed, directly or indirectly in the Other Countries. Any party who receives the abovementioned documents must not distribute, send or transmit them (either by post nor by any other method or instrument of communication or commerce) in the Other Countries.</div><div><br></div><div>This press release, as well as any other document that has or will be issued in connection with the Offer does not constitute and cannot be interpreted as an offer to purchase or solicitation of an offer to sell financial instruments to parties resident in Other Countries. No instrument may be offered or sold in the Other Countries in the absence of specific authorisation in compliance with the applicable provisions of the local law of those countries or in derogation of those provisions. Tenders in the Offer by parties resident in countries other than Italy and the United States of America may be subject to specific obligations or restrictions provided by law or regulatory provisions. Parties who wish to take part in the Offer bear the exclusive responsibility to comply with those laws and therefore prior to tendering their Common Shares in the Offer, those parties are required to verify their possible existence and applicability, consulting their own advisors.</div><div><br></div><div>This press release contains forward-looking information and statements. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates" and similar expressions. Investors and holders of IVG shares are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of the Offeror and IVG, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public documents sent by the Offeror to Consob. Except as required by applicable law, the Offeror and IVG do not undertake any obligation to update any forward-looking information or statements.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 11:52:00 +0700</pubDate>
</item>
<item>
<title>How the &quot;Dual Olympic City&quot; Activates the Sports Event Economy</title>
<link>https://relleaseid.com/berita-bisnis/How-the--quot-Dual-Olympic-City-quot--Activates-the-Sports-Event-Economy</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4059_How-the--quot-Dual-Olympic-City-quot--Activates-the-Sports-Event-Economy.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div><br></div><div><div>This is the Grand Smash Park at Shougang Park in Beijing, photographed on October 4</div><div><br></div></div><div>BEIJING, CHINA - Media OutReach Newswire - 9 October 2026 - On the evening of October 6, after Djokovic won the first set of the men&#039;s singles final, his opponent Alex de Minaur retired due to injury, giving Djokovic his seventh China Open title.</div><div><br></div><div>During the tournament, the excitement of the China Open extended from the courts to the entire park. The "second venue" with big-screen viewing, a rich variety of officially licensed merchandise, and food and beverage outlets full of everyday bustle blended the passion of sports competition with the city&#039;s relaxed atmosphere, creating a diverse holiday viewing experience.</div><div><br></div><div>"After entering through the two ticket gates-north and south-of the National Tennis Center, there are officially licensed merchandise stores at both locations. During the National Day holiday, each of these two stores received over 10,000 visitors a day. Nearly a thousand products give everyone&#039;s tournament memories a tangible carrier," said Yin Xufei, head of the China Open officially licensed merchandise store.</div><div><br></div><div>Also thriving thanks to the events is Shougang Park in Shijingshan, Beijing. The World Table Tennis (WTT) China Grand Smash held in this industrial-style park echoed the China Open during the National Day holiday for the third consecutive year, giving the most vivid footnote to the "Golden Week of Sports Events."</div><div><br></div><div>"People can spend a whole day wandering around Shougang Park-dining, markets, and souvenirs are all available. Besides going into the venue to watch matches and cheer for the athletes, you can also feel the festive atmosphere of table tennis, China&#039;s national sport, blending with the National Day holiday at the Grand Smash Park," said Gao Yize, a fan from Xinjiang.</div><div><br></div><div>At the WTT China Grand Smash official licensed store, visitors and tourists stopped to learn about the tournament-themed T-shirt that lets you "Explore Shijingshan in One T-Shirt." For those familiar with the "ticket stub economy," this T-shirt is a "walking ticket stub." Wearing the benefits during the tournament gives you access to exclusive discounts on dining, accommodation, and sightseeing at hundreds of partner merchants in Shougang Park, Yongdingheji, Moshikou Historical and Cultural Street, and other locations.</div><div><br></div><div>The "Golden Week of Sports Events" ignited a city. Led by high-level international events such as the China Open and the WTT China Grand Smash, competitive sports, mass sports, and youth sports events at all levels covered the north, south, east, and west of the "Dual Olympic City" and integrated into its streets and alleys.</div><div><br></div><div>During the National Day holiday, the Beijing Yizhuang GT World Challenge attracted over 26,000 spectators. By Tongming Lake, engines roared, and speed and passion were set against the lake and city scenery. The automobile-themed carnival, integrating race viewing, car culture, technology interaction, and leisure consumption, drove significant growth in surrounding dining, retail, and accommodation spending. </div><div><br></div><div>In Miyun on the outskirts of Beijing, the China Men&#039;s 3x3 Basketball League Championship linked cultural tourism resources and key commercial districts, opening the "Chao San" Market that brought together over 30 merchants offering Miyun&#039;s Three Roasts, intangible cultural heritage "loufen" (starch noodles), and other specialties, allowing fans to enjoy food and buy local products after watching the games...</div><div><br></div><div>The "Dual Olympic City" has made holiday cultural tourism scenarios a standard feature of sports events, expanding event consumption scenarios and enhancing the event consumption experience, further demonstrating the enormous potential of the sports event economy.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 11:48:00 +0700</pubDate>
</item>
<item>
<title>Sigenergy Unveils the Latest Energy Solutions at Malaysia&#039;s IGEM 2026</title>
<link>https://relleaseid.com/berita-bisnis/Sigenergy-Unveils-the-Latest-Energy-Solutions-at-Malaysia--039-s-IGEM-2026</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/1302_Sigenergy-Unveils-the-Latest-Energy-Solutions-at-Malaysia--039-s-IGEM-2026.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>KUALA LUMPUR, Malaysia, Oct. 10, 2026 (GLOBE NEWSWIRE) -- Sigenergy is making its third appearance at the International Greentech & Eco Products Exhibition & Conference Malaysia (IGEM), showcasing its latest intelligent energy solutions and strengthening strategic partnerships across the Malaysian market.</div><div><br></div><div>A key highlight of the event is the keynote presentation, "Sigenergy: Innovating with AI, Powering the Future Together," which explores how AI-driven innovation is shaping the next generation of smart energy systems and supporting the transition toward a more sustainable energy future.</div><div><br></div><div>Sigenergy also marked an important milestone in its local ecosystem through MOU exchanges with strategic partners Milieu and YT Energy, a subsidiary of Yayasan Pahang, reinforcing collaboration to accelerate the adoption of advanced energy solutions in Malaysia.</div><div><br></div><div>At the exhibition, Sigenergy is showcasing solutions across residential, C&I and utility applications, including SigenStor Neo, SigenStack, and its Utility Solution featuring the Sigen PV 500H1 inverter and SigenTerra BESS, demonstrating its capabilities in delivering scalable, intelligent and reliable energy solutions for diverse applications.</div><div><br></div><div>About Sigenergy</div><div><br></div><div>Founded in 2022 and headquartered in Shanghai, Sigenergy (6656.HK) is a technology-driven company focused on innovation in the new energy sector. Leveraging advanced digital intelligence and a highly skilled talent base, the company has expanded across photovoltaic(PV)generation, smart energy storage and high-efficiency electric vehicle (EV) charging solutions.</div><div><br></div><div>Guided by its "AI in All" strategy, Sigenergy integrates artificial intelligence across its product ecosystem to deliver safer, smarter and more efficient energy solutions for households and businesses worldwide.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 11:43:00 +0700</pubDate>
</item>
<item>
<title>Iveco Group welcomes the increase of the offer price of the voluntary totalitarian tender offer for all its common shares launched by TML CV Holdings B.V.</title>
<link>https://relleaseid.com/berita-bisnis/Iveco-Group-welcomes-the-increase-of-the-offer-price-of-the-voluntary-totalitarian-tender-offer-for-all-its-common-shares-launched-by-TML-CV-Holdings-B-V-</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/1654_Iveco-Group-welcomes-the-increase-of-the-offer-price-of-the-voluntary-totalitarian-tender-offer-for-all-its-common-shares-launched-by-TML-CV-Holdings-B-V-.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION</div><div><br></div><div>Turin, 9th October 2026. With reference to the voluntary totalitarian tender offer (the "Offer") promoted by TML CV Holdings Pte. Ltd., through the wholly-owned company TML CV Holdings B.V. (the "Offeror"), under Articles 102 et seq. of CFA (as defined in the Offer Document), for all the common shares of Iveco Group N.V. ("IVG" or the "Issuer") (the "Common Shares"), IVG has taken note of the increase of the price of the Offer, as announced today by the Offeror in its press release pursuant to Articles 36 and 43 of the Issuer&#039;s Regulation (as defined in the Offer Document), from Euro 14.10 (cum dividend) to Euro 14.40 (cum dividend) for each Common Share tendered to the Offer, providing for a cash increase of Euro 0.30 for each Common Share.</div><div><br></div><div>Iveco Group welcomes the increase in the Offer Price. The Offer is supported by the Board of Directors of IVG, that recommended it for acceptance by the Company&#039;s shareholders, and recommended them to vote in favour of the resolutions relating to the Offer at the extraordinary general meeting convened on Friday 16 October 2026.</div><div><br></div><div>Capitalised terms used in this press release, unless otherwise defined, shall have the meanings ascribed to them in the Offer Document. For any information regarding the Offer, reference is made to the Offer Document and the relevant press releases on the Offer, which are published by the Offeror in accordance with the procedures prescribed by applicable laws and regulations. The press releases and documents relating to the Offer are available, inter alia, on the website of the Issuer at www.ivecogroup.com.</div><div><br></div><div>* * *</div><div>IMPORTANT NOTICE</div><div><br></div><div>THE DISSEMINATION, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE IS PROHIBITED IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE APPLICABLE LAWS OR REGULATIONS OF THAT JURISDICTION</div><div><br></div><div>This press release or the information contained herein will not be disseminated, published or distributed in Canada, Japan and Australia, nor in any other country other than Italy and the United States of America in which the Offer is not permitted in the absence of the authorization of the competent authorities or would be in breach of laws or regulations (such countries, including Canada, Japan and Australia, jointly, the "Other Countries").</div><div><br></div><div>This press release, the information contained herein and any portion thereof may not be sent, transmitted or distributed, directly or indirectly, in or into the Other Countries. Any person receiving this press release or the information contained herein must not send, transmit or distribute it, in whole or in part, in or into the Other Countries.</div><div><br></div><div>Iveco Group N.V. (EXM: IVG) is a global player in the automotive industry, built on a strong Italian heritage and with a consolidated international reach. The Group channels decades of engineering excellence and innovation into sustainable mobility and customer driven technologies. Its five brands play a leading role in their respective domains: IVECO, a pioneering commercial vehicles brand offering heavy, medium and light duty trucks; FPT, a global leader in advanced powertrain technologies in the agriculture, construction, marine, power generation and commercial vehicles sectors; IVECO BUS and HEULIEZ, renowned for their mass transit, premium bus and coach solutions; and IVECO CAPITAL, the Group&#039;s financing arm supporting them all. Iveco Group employs 33,000 people and operates 16 industrial sites and 22 R&D centres. Further information is available at www.ivecogroup.com</div><div><br></div><div>Media Contacts:</div><div>Francesco Polsinelli, Tel: +39 335 1776091</div><div>Fabio Lepore, Tel: +39 335 7469007</div><div>E-mail: mediarelations@ivecogroup.com</div><div><br></div><div>Investor Relations:</div><div>Federico Donati, Tel: +39 011 0073539</div><div>E-mail: investor.relations@ivecogroup.com</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 11:36:00 +0700</pubDate>
</item>
<item>
<title>YYForce Memperluas Cakupan 24iFM dengan Marketplace Layanan dan Periklanan Lifestyle</title>
<link>https://relleaseid.com/berita-bisnis/YYForce-Memperluas-Cakupan-24iFM-dengan-Marketplace-Layanan-dan-Periklanan-Lifestyle</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4_YYForce-Memperluas-Cakupan-24iFM-dengan-Marketplace-Layanan-dan-Periklanan-Lifestyle.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>*Tonggak Pencapaian Strategis: Ekspansi komersial 24iFM mengintegrasikan pengelolaan properti, layanan rumah tangga sesuai permintaan, dan promosi merchant gaya hidup ke dalam satu platform digital.</div><div>*Pertumbuhan Digital Regional: Laporan e-Conomy SEA 2025 yang diterbitkan oleh Google, Temasek, dan Bain & Company memproyeksikan bahwa ekonomi digital Asia Tenggara akan melampaui nilai transaksi bruto sebesar US$300 miliar pada tahun 2025.</div><div>*Jalur Komersial: Komisi transaksi, biaya layanan, serta pendapatan dari periklanan dan promosi merchant berpotensi menjadi sumber pendapatan digital baru di samping kegiatan operasional IFM YYForce yang telah berjalan.</div><div><br></div><div>SINGAPURA, Oct. 09, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (NASDAQ: YFOR) ("YYForce" atau "Perusahaan"), penyedia platform pengelolaan tenaga kerja berkemampuan AI dan pengelolaan fasilitas terpadu ("IFM") yang beroperasi di Asia dan berbagai wilayah lainnya, hari ini mengumumkan ekspansi komersial 24iFM melalui fitur Marketplace Layanan dan periklanan Lifestyle ("Ekspansi"). Ekspansi ini mengintegrasikan administrasi pengelolaan properti, layanan rumah tangga sesuai permintaan, serta promosi merchant ke dalam satu platform digital.</div><div><br></div><div>Ekspansi ini membuka peluang terciptanya dua sumber pendapatan digital baru di samping kegiatan usaha IFM YYForce yang telah berjalan. Kedua sumber tersebut mencakup komisi atau biaya layanan dari transaksi marketplace yang telah selesai dan memenuhi persyaratan, serta pendapatan dari pemasangan iklan dan promosi oleh merchant yang berpartisipasi. Perolehan pendapatan akan bergantung pada tingkat adopsi pengguna, jumlah transaksi yang berhasil diselesaikan, serta perjanjian komersial dengan penyedia layanan dan merchant.</div><div><br></div><div>Dari Pengelolaan Fasilitas Menjadi Marketplace Layanan Digital</div><div>24iFM mengintegrasikan berbagai fungsi yang sebelumnya dijalankan melalui sistem terpisah. Platform ini mengintegrasikan berbagai fungsi pengelolaan properti dan fasilitas sehari-hari, termasuk pemesanan fasilitas, pendaftaran pengunjung, formulir digital, pembayaran, serta komunikasi terkait pengelolaan properti. Integrasi ini juga mencakup marketplace yang terus berkembang untuk menyediakan berbagai layanan terkait rumah tangga dan properti.</div><div><br></div><div>Melalui Marketplace Layanan 24iFM, pengguna dapat menemukan dan memesan layanan dari penyedia layanan yang berpartisipasi. YYForce memperkirakan akan turut serta dalam aktivitas layanan yang memenuhi persyaratan melalui platform ini dengan mengenakan komisi atau biaya layanan, sesuai dengan kesepakatan komersial yang berlaku.</div><div><br></div><div>Lifestyle Menghadirkan Saluran Periklanan Digital</div><div>Selain Marketplace Layanan, YYForce juga memperluas fitur Lifestyle pada platform 24iFM untuk menghubungkan pengguna dengan merchant dan penyedia layanan yang berpartisipasi. Fitur ini mencakup berbagai kategori, seperti kebugaran, pendidikan, kecantikan, kesehatan, layanan hewan peliharaan, olahraga, serta segmen gaya hidup lainnya.</div><div><br></div><div>Fitur Lifestyle ini dirancang untuk membuka peluang sumber pendapatan tambahan melalui periklanan. Produk periklanan yang berpotensi ditawarkan meliputi penempatan merchant di posisi unggulan, penempatan bersponsor pada kategori tertentu, kampanye promosi, serta berbagai bentuk promosi berbayar lainnya untuk meningkatkan visibilitas di platform digital.</div><div><br></div><div>Dua Saluran Monetisasi dalam Satu Ekosistem Digital</div><div>Ekspansi komersial 24iFM menghadirkan arsitektur pendapatan digital yang melengkapi, di samping kegiatan operasional pengelolaan fasilitas YYForce yang telah berjalan. Marketplace Layanan dirancang untuk mendukung perolehan pendapatan dari komisi berbasis transaksi atau biaya layanan. Sementara itu, fitur Lifestyle dirancang untuk mendukung perolehan pendapatan dari periklanan dan promosi merchant yang berpartisipasi.</div><div><br></div><div>Kedua fitur ini bertujuan untuk meningkatkan potensi ekonomi dari hubungan bisnis YYForce di sektor properti dengan membuka peluang kegiatan komersial digital di komunitas yang dilayaninya.</div><div><br></div><div>"24iFM memperluas cakupan hubungan bisnis kami di sektor properti, tidak lagi terbatas pada pengelolaan fasilitas konvensional," ujar Mike Fu, Chairman dan Chief Executive Officer YYForce. "Melalui satu platform digital, kami menghubungkan pengguna properti dengan penyedia layanan dan merchant. Dengan memanfaatkan jaringan operasional IFM yang sudah ada, kami membuka peluang sumber pendapatan tambahan dari transaksi dan periklanan. Dengan meningkatnya adopsi pengguna, kami juga menargetkan peningkatan jumlah interaksi komersial yang dapat berlangsung melalui ekosistem 24iFM."</div><div><br></div><div>Kondisi Pasar di Singapura dan Asia Tenggara</div><div>Singapura menjadi pasar awal bagi layanan digital yang terhubung dengan properti. Menurut data Departemen Statistik Singapura, Singapura memiliki 381.996 unit kondominium dan apartemen lainnya per Juni 2026. Jumlah hunian tersebut memberikan gambaran mengenai jenis komunitas perumahan yang menjadi sasaran layanan 24iFM. Namun, angka tersebut tidak mencerminkan jumlah rumah tangga atau pelanggan yang telah terdaftar di platform Perusahaan.</div><div><br></div><div>Ekspansi 24iFM dilakukan di tengah meningkatnya penggunaan layanan digital di kawasan Asia Tenggara. Menurut laporan e-Conomy SEA 2025 yang diterbitkan oleh Google, Temasek, dan Bain & Company, nilai transaksi bruto ekonomi digital Asia Tenggara diproyeksikan melampaui US$300 miliar pada tahun 2025. Angka tersebut memberikan gambaran mengenai kondisi pasar perdagangan digital secara lebih luas di kawasan Asia Tenggara. Namun, angka ini bukan merupakan estimasi potensi pasar yang dapat dijangkau oleh 24iFM maupun proyeksi pendapatannya.</div><div><br></div><div>Cakupan komersial 24iFM bertumpu pada ekosistemnya yang terhubung dengan properti. Potensi monetisasi platform ini akan bergantung pada tingkat adopsi di komunitas hunian dan komersial yang berpartisipasi, serta frekuensi pemesanan layanan yang berhasil diselesaikan. Faktor lainnya mencakup kesepakatan komersial dengan penyedia layanan dan tingkat permintaan terhadap promosi merchant berbayar.</div><div><br></div><div>Meningkatkan Skala Ekosistem 24iFM</div><div>YYForce berencana memperluas secara bertahap jumlah penyedia layanan dan merchant yang berpartisipasi, serta ragam kategori layanan dan penawaran komersial yang tersedia melalui 24iFM. Perluasan ini akan dilakukan berdasarkan permintaan pasar dan tingkat adopsi platform.</div><div><br></div><div>Dengan bertambahnya jumlah properti, pengguna, penyedia layanan, dan merchant yang berpartisipasi dalam ekosistem ini, 24iFM dirancang untuk mendukung peningkatan ragam interaksi. Setiap peluang komersial baru pun dapat diwujudkan tanpa harus melalui kontrak pengelolaan fasilitas tersendiri.</div><div><br></div><div>Komersialisasi 24iFM merupakan bagian dari strategi YYForce yang lebih luas untuk memadukan kehadiran operasionalnya dengan teknologi, otomatisasi, dan platform digital. Dalam ekosistem ini, 24iFM dimaksudkan berperan sebagai lapisan interaksi digital yang menghubungkan operasional pengelolaan fasilitas dengan layanan sehari-hari dan kegiatan komersial.</div><div><br></div><div>Sumber Data Pasar</div><div><br></div><div>Departemen Statistik Singapura, Hunian Tempat Tinggal, Tahunan. Data per akhir Juni 2026.&nbsp;</div><div>Google, Temasek dan Bain & Company, e-Conomy SEA 2025. Angka-angka tersebut merupakan proyeksi yang dipublikasikan pada 11 November 2025.&nbsp;</div><div><br></div><div>Tentang YYForce Inc.</div><div>YYForce Inc. (Nasdaq: YFOR) adalah penyedia layanan pengelolaan tenaga kerja berkemampuan AI dan pengelolaan fasilitas terintegrasi, yang berkantor pusat di Singapura serta beroperasi di Asia dan wilayah lainnya. Platform solusi tenaga kerja cerdas milik Perusahaan, YY Circle, membantu klien di sektor perhotelan, makanan dan minuman, ritel, serta sektor jasa lainnya untuk memprediksi, merencanakan, dan mengoptimalkan penempatan tenaga kerja. Dalam bisnis IFM YYForce, platform perangkat lunak 24iFM dan portofolio komprehensif anak perusahaan yang bergerak di bidang IFM mendukung klien di sektor perhotelan, transportasi, perbankan, ritel, serta fasilitas multifungsi.</div><div><br></div><div>Dengan semakin berkembangnya kedua lini bisnis tersebut, Perusahaan secara sistematis mengintegrasikan kemampuan AI dan otomatisasi, mulai dari dukungan pengambilan keputusan cerdas hingga pengelolaan tenaga kerja yang semakin otonom. Langkah ini bertujuan untuk meningkatkan kualitas layanan, mengurangi biaya penempatan tenaga kerja, dan mendorong peningkatan margin dalam jangka panjang. Sebagai perusahaan yang tercatat di Nasdaq Capital Market, YYForce berkomitmen terhadap inovasi infrastruktur, pencapaian hasil yang terukur bagi klien, serta penciptaan nilai jangka panjang.</div><div><br></div><div>Pernyataan Berwawasan ke Depan</div><div>Siaran pers ini memuat pernyataan berwawasan ke depan sebagaimana dimaksud dalam Pasal 27A Undang-Undang Sekuritas AS Tahun 1933, sebagaimana telah diubah, dan Pasal 21E Undang-Undang Perdagangan Sekuritas AS Tahun 1934, sebagaimana telah diubah. Perusahaan menyusun pernyataan berwawasan ke depan ini berdasarkan ekspektasi dan proyeksinya terhadap peristiwa di masa mendatang, dengan mengacu pada informasi yang tersedia bagi Perusahaan saat ini. </div><div><br></div><div>Anda dapat mengidentifikasi pernyataan berwawasan ke depan dari sifatnya yang tidak berkaitan dengan peristiwa historis, terutama pernyataan yang menggunakan istilah seperti "mungkin," "seharusnya," "mengharapkan," "mengantisipasi," "mempertimbangkan," "memperkirakan," "meyakini," "merencanakan," "diproyeksikan," "memprediksi," "potensial," atau "berharap" maupun bentuk negatif dari istilah-istilah tersebut atau istilah serupa. Pernyataan berwawasan ke depan mencakup pernyataan mengenai pengembangan, adopsi, komersialisasi, monetisasi, dan ekspansi 24iFM serta fitur Marketplace Layanan dan Lifestyle yang diharapkan oleh Perusahaan. </div><div><br></div><div>Pernyataan tersebut mengandung risiko dan ketidakpastian, serta peristiwa dan hasil sebenarnya dapat berbeda secara signifikan. Faktor-faktor yang dapat menyebabkan hasil sebenarnya berbeda secara signifikan termasuk, tetapi tidak terbatas pada, kemampuan Perusahaan untuk menarik dan mempertahankan pengguna, penyedia layanan, dan merchant di platform 24iFM, serta kecepatan dan tingkat adopsi pasar, ketergantungan pada penyedia layanan pihak ketiga dan kesepakatan komersial, perkembangan regulasi di pasar tempat Perusahaan beroperasi, kondisi persaingan, serta kemampuan Perusahaan dalam menjalankan strategi pertumbuhan dan monetisasinya. Untuk pembahasan lebih terperinci mengenai faktor-faktor risiko, silakan merujuk pada dokumen yang diserahkan Perusahaan kepada Komisi Sekuritas dan Bursa AS (SEC), termasuk bagian "Faktor Risiko" dalam laporan tahunan terbaru Perusahaan pada Formulir 20-F, sebagaimana telah diubah. Perusahaan tidak berkewajiban untuk memperbarui atau merevisi pernyataan berwawasan ke depan apa pun untuk publik, baik karena adanya informasi baru, peristiwa di masa mendatang, maupun alasan lainnya, kecuali jika diwajibkan oleh hukum.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 11:31:00 +0700</pubDate>
</item>
<item>
<title>VCI Global Clarifies Structure of US$125 Million Standby Equity Purchase Facility, Emphasizes Flexible Capital Strategy</title>
<link>https://relleaseid.com/berita-bisnis/VCI-Global-Clarifies-Structure-of-US-125-Million-Standby-Equity-Purchase-Facility--Emphasizes-Flexible-Capital-Strategy</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/3036_VCI-Global-Clarifies-Structure-of-US-125-Million-Standby-Equity-Purchase-Facility--Emphasizes-Flexible-Capital-Strategy.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>KUALA LUMPUR, Malaysia, Oct. 09, 2026 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) ("VCI Global" or the "Company") today provided clarification regarding its recent Form D filing with the U.S. Securities and Exchange Commission (SEC) in connection with its US$125 million standby Equity Purchase Agreement (EPA) with Hudson Global Ventures, LLC.</div><div><br></div><div>The Company clarified that the agreement establishes a standby equity purchase facility, commonly referred to as an equity line of credit (ELOC). The facility provides VCI Global with the option to access capital over a 36-month period, subject to the terms and conditions of the agreement. The US$125 million represents the facility&#039;s stated maximum size and does not constitute an immediate issuance or sale of US$125 million in ordinary shares.</div><div><br></div><div>As of the date of this announcement, VCI Global has not drawn any funds under the facility, and no ordinary shares have been issued pursuant to the agreement.</div><div><br></div><div>Flexible Capital Access at the Company&#039;s Discretion</div><div><br></div><div>The facility is intended to provide VCI Global with an additional source of potential capital as it advances its business priorities. Rather than requiring the Company to raise the entire amount upfront, the arrangement allows it to evaluate potential drawdowns based on its capital requirements, business opportunities and prevailing market conditions, subject to the agreement&#039;s terms.</div><div><br></div><div>Key features of the facility include:</div><div><br></div><div>No utilization to date: No funds have been drawn and no ordinary shares have been issued under the facility as of October 9, 2026.</div><div>Flexible drawdown structure: The Company may elect whether and when to seek funding, and the amount requested, subject to the agreement&#039;s terms and applicable requirements.</div><div>36-month availability period: The facility provides a potential source of capital over the agreement&#039;s stated term, offering flexibility in planning future funding needs.</div><div>Capital deployment aligned with growth priorities: Any proceeds raised may be allocated to eligible business initiatives based on the Company&#039;s strategic priorities and capital requirements.</div><div><br></div><div>Any future drawdowns and associated share issuances would depend on the terms of the agreement, applicable regulatory requirements and relevant market conditions. The facility does not eliminate the possibility of dilution if ordinary shares are issued in connection with future drawdowns.</div><div><br></div><div>Potential Funding to Support AI Infrastructure and Renewable Energy</div><div><br></div><div>If the facility is utilized, VCI Global expects to consider allocating proceeds toward its key growth areas, particularly AI infrastructure and platforms, as well as renewable energy projects.</div><div><br></div><div>AI Infrastructure and Platforms</div><div><br></div><div>The Company intends to continue advancing its AI-related initiatives, including high-performance computing infrastructure, AI platforms and large language model (LLM) deployment capabilities through its VGAIN and Galatron AI ecosystems. Potential investments may support infrastructure expansion, platform development and the broader deployment of AI-related services.</div><div><br></div><div>Renewable Energy</div><div><br></div><div>The Company is also pursuing opportunities in renewable energy generation and sustainable power infrastructure. These initiatives align with the growing importance of reliable and sustainable energy supply in supporting energy-intensive industries, including AI computing and data center operations.</div><div><br></div><div>The allocation of any proceeds will depend on the Company&#039;s evolving business needs, the availability of suitable investment opportunities and management&#039;s assessment of the expected strategic value of each initiative.</div><div><br></div><div>"We believe this structure allows us to evaluate potential capital needs and deployment opportunities over time, with drawdown decisions guided by our business priorities, market conditions and the terms of the agreement. We remain focused on taking a disciplined approach to capital allocation as we pursue our longer-term growth objectives," said Victor Hoo, Group Chief Executive Officer and Executive Chairman of VCI Global.</div><div><br></div><div>About VCI Global Limited</div><div><br></div><div>VCI Global Limited (NASDAQ: VCIG) is an AI-native operating platform designed to scale and optimize businesses through centralized intelligence, data, and capital discipline.</div><div><br></div><div>The Company operates a platform-based model in which subsidiaries, affiliates, and portfolio companies plug into VCI Global&#039;s centralized AI, data, governance, and capital allocation systems, enabling faster execution, improved capital efficiency, and scalable growth across multiple industries.</div><div><br></div><div>VCI Global&#039;s platform centralizes AI-enabled execution, standardized KPI frameworks, financial and governance controls, and strategic capital allocation, while operating businesses focus on revenue generation, customer relationships, and local execution.</div><div><br></div><div>The Company maintains exposure across advisory, AI, and digital infrastructure, digital assets, energy, automotive, and consumer sectors, and continuously evaluates opportunities to scale, spin off, divest, or discontinue businesses based on performance, scalability, and return on capital.</div><div><br></div><div>VCI Global&#039;s platform-centric approach is designed to enhance productivity, improve IPO readiness, and unlock long-term value through disciplined growth and selective capital deployment.</div><div><br></div><div>Cautionary Note Regarding Forward-Looking Statements</div><div><br></div><div>This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company&#039;s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. These forward-looking statements are based only on our current beliefs, expectations, and other future conditions. </div><div><br></div><div>Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking statements.</div><div><br></div><div> Actual results could differ materially from those described in these forward-looking statements due to certain factors, including without limitation, the Company&#039;s ability to achieve profitable operations, customer acceptance of new products, the effects of the spread of coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company&#039;s products and the Company&#039;s customers&#039; economic condition, the impact of competitive products and pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company&#039;s filings with the United States Securities and Exchange Commission ("SEC"). </div><div><br></div><div>The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except in accordance with applicable law.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 11:26:00 +0700</pubDate>
</item>
<item>
<title>LANDMARK Launches &#039;Destination CENTRAL&#039;: A District-Wide Invitation to Explore the Dynamism, Luxury, and Soul of Central</title>
<link>https://relleaseid.com/berita-bisnis/LANDMARK-Launches---039-Destination-CENTRAL--039---A-District-Wide-Invitation-to-Explore-the-Dynamism--Luxury--and-Soul-of-Central</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/3668_LANDMARK-Launches---039-Destination-CENTRAL--039---A-District-Wide-Invitation-to-Explore-the-Dynamism--Luxury--and-Soul-of-Central.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Guided by the Central Passport, LANDMARK invites visitors to experience Central anew - from Louis Vuitton&#039;s global spectacle to cultural, dining and seasonal celebrations.</div><div><br></div><div>HONG KONG SAR - Media OutReach Newswire - 9 October 2026 - LANDMARK today unveils Destination CENTRAL, inviting local residents and international visitors to rediscover the many sides of Central through the collectible Central Passport. The programme celebrates the district&#039;s long-standing role as Hong Kong&#039;s gateway for arrival, exchange and discovery.</div><div><br></div><div> Inspired by the spirit of travel, Destination CENTRAL connects experiences across Central, bringing together travel-inspired activations in partnership with Hong Kong Tramways and Asia Miles; district-wide dining privileges; a global spectacle by Louis Vuitton; and THE CHATER, an exclusive dining concept presented by LANDMARK.</div><div><br></div><div>Your Passport to Central</div><div><br></div><div>Created by LANDMARK, the luggage-inspired Central Passport is a collectible guide bringing together experiences both within LANDMARK and across the wider district into a seamless journey. Inside, a curated map is paired with personal stories and recommendations from people who know Central closely-from tram motormen, singers and public figures to athletes, celebrated chefs and bar founders-inviting visitors to uncover the area&#039;s hidden character.</div><div><br></div><div>Available from collection points across the district, the Central Passport can be personalised with stamps from eight designated locations. Visitors who collect any three stamps can visit the Destination CENTRAL Redemption Counter on 2/F, LANDMARK ATRIUM to enter a lucky draw and unlock a surprise gift. Lucky winners stand a chance to receive up to 66,000 Asia Miles-equivalent to a round-trip business-class flight to Japan-alongside photobooth experiences, limited-edition keepsakes and dining vouchers. The Central Passport also includes exclusive dining privileges from more than 40 participating partners, including Lan Kwai Fong and The Murray.</div><div><br></div><div>Louis Vuitton at LANDMARK</div><div><br></div><div>Following iconic presentations on the Champs-?lys?es in Paris, 57th Street in New York and &#039;The Louis&#039; in Shanghai, Louis Vuitton brings the latest chapter of its global series to Hong Kong. Unveiling soon, the Maison will present a monumental mega-art installation at LANDMARK, reimagining its enduring "Spirit of Travel". Complemented by the pop-up store currently at LANDMARK ATRIUM and the upcoming dedicated Basement Brand Exhibition , the experience offers a captivating glimpse into the world of Louis Vuitton-setting the stage for the highly anticipated Louis Vuitton Maison at LANDMARK.</div><div><br></div><div>Transit Through Central&#039;s Changing Landscape</div><div><br></div><div>The travel narrative continues with the LANDMARK Tram Station and Heritage Route, created in partnership with Hong Kong Tramways. Together, they offer an interactive look at Central&#039;s transport heritage and evolving urban landscape-from its early harbourfront and trading past to today&#039;s connected city centre. The LANDMARK Tram Station recreates one of the city&#039;s first-generation trams, fitted with authentic archive pieces from Hong Kong Tramways, including a traditional ticket punch, a coin box, driving console and "Dick, Kerr" controller.</div><div><br></div><div>A First Class Stop for Dining and Views</div><div><br></div><div>Taking the travel theme into hospitality, LANDMARK presents THE CHATER, an exclusive dining concept opening on 6 October, featuring an all-day menu curated by Mandarin Oriental, Hong Kong. Inspired by the elegance and anticipation of a grand station lounge, the new venue brings together Hong Kong and international flavours, with highlights including bubble tea and gourmet quick bites, alongside Pierre Herm? macarons and gelato set to be launched later in the season. </div><div><br></div><div>The experience will extend to Platform 1889 on 3/F, a first-class railway carriage-inspired feature within THE CHATER&#039;s terrace. Named for the year Sir Paul Chater co-founded Hongkong Land, Platform 1889 pays tribute to a defining moment in Central&#039;s history while offering a prime view of Louis Vuitton&#039;s monumental mega-art installation and the Central skyline.</div><div><br></div><div>Halloween Takes Over Central</div><div><br></div><div>From 17 to 31 October, Hongkong Land, supported by the Hong Kong Tourism Board and district partners, presents Halloween in Central-a heritage-led celebration that transforms Central&#039;s iconic streetscape into a citywide Halloween playground.</div><div><br></div><div>At Statue Square Gardens, South, four large-scale installations set a striking scene: I Am Watching You, a giant eyeball rising over the fountain; The Awakening, a monumental gateway; the photo-ready Coffin Throne; and The Jail, a haunted reimagining of the pavilion.</div><div><br></div><div>On Chater Road, the programme begins with Boo-st Your Mood - Pickleball Day in partnership with Pick & Match on 17 October, a wellness-focused afternoon of active fun. This is followed by OPEN by HE.R - Halloween in Central Kick-Off Party on 18 October, bringing live music and high-energy celebrations to the street. Monster Mash Fest - Family Day arrives on 24 October with costumes, face painting, themed bouncy-castle sessions, performances and Halloween treats, before Halloween Day Unleashed closes the programme on 31 October, featuring cosplay, roving characters, themed performances and late-night festivities. Full details are available at https://www.halloweenincentral.com/</div><div><br></div><div>"As a key stakeholder deeply rooted in Central, Hongkong Land is delighted to bring Destination CENTRAL to life alongside our district partners, inviting the public to discover the extraordinary charm of Central anew," said Olivia Luk, General Manager, Marketing, Hong Kong Central, Hongkong Land Limited. "Together with a rich programme of dining privileges and seasonal celebrations, we hope everyone-from daily office workers and local residents to visitors-can shape their own memorable story of Central."</div><div><br></div><div>Exclusive Rewards and Privileges</div><div><br></div><div>Destination CENTRAL brings added benefits to every qualifying LANDMARK visit with HSBC-exclusive offers for BESPOKE members. From 28 September to 18 November 2026, eligible BESPOKE members paying with an HSBC Prive Mastercard or HSBC Premier Mastercard can receive up to HK$3,000 in BESPOKE Bonus Reward Vouchers, up to 135,000 Bonus BESPOKE Points, and Complimentary Beverage Passes to Platform 1889 at THE CHATER upon registration of cumulative same-day eligible spending.</div><div><br></div><div>Terms and conditions apply. For full programme and promotional details, including specific Central Passport mechanisms, please visit https://destinationcentral.hk.</div><div><br></div><div>@landmarkhk #LANDMARKHK #DestinationCENTRAL</div><div><br></div><div>APPENDIX</div><div><br></div><div>Please visit the Destination CENTRAL website at https://destinationcentral.hk for the latest programme details, terms and conditions.</div><div><br></div><div>Central Passport Collection & Reward Details (28 September - 18 November 2026)</div><div><br></div><div><table style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px; background-color: rgb(255, 255, 255); width: 550px; border: 1px solid rgb(0, 0, 0); overflow: revert;"><tbody><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;"><b>Collection Points</b><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;"><b>Stamp Station Checkpoints</b><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Over 20 Collection Points across Central, including:<br><br><ul><li style="margin-left: 15px;">Destination CENTRAL Stamping Stations</li><li style="margin-left: 15px;">Destination CENTRAL Redemption Counter (2/F, LANDMARK ATRIUM)</li><li style="margin-left: 15px;">Destination CENTRAL Photobooth (3/F, LANDMARK ATRIUM)</li><li style="margin-left: 15px;">LANDMARK Concierges</li><li style="margin-left: 15px;">Hongkong Land Office Lobby Concierges</li><li style="margin-left: 15px;">The Plaza LKF Lobby (<a href="https://www.google.com/maps/search/21+D&#039;Aguilar+Street,+Central?entry=gmail&source=g" data-saferedirecturl="https://www.google.com/url?q=https://www.google.com/maps/search/21%2BD&#039;Aguilar%2BStreet,%2BCentral?entry%3Dgmail%26source%3Dg&source=gmail&ust=1791689832516000&usg=AOvVaw1oPSUVrkOF7j8YFMcjkiqn" style="color: rgb(17, 85, 204);">21 D&#039;Aguilar Street, Central</a>)</li><li style="margin-left: 15px;">HSBC Main Building (LG/F,&nbsp;<a href="https://www.google.com/maps/search/1+Queen&#039;s+Road+Central?entry=gmail&source=g" data-saferedirecturl="https://www.google.com/url?q=https://www.google.com/maps/search/1%2BQueen&#039;s%2BRoad%2BCentral?entry%3Dgmail%26source%3Dg&source=gmail&ust=1791689832516000&usg=AOvVaw0ah16_A38Urs0TthI6XrMW" style="color: rgb(17, 85, 204);">1 Queen&#039;s Road Central</a>&nbsp;-&nbsp;Until 7 October)</li></ul>Please refer to the website for the complete list of collection points.<br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Eight Designated Checkpoints Across Central<br><br><ul><li style="margin-left: 15px;">Louis Vuitton Pop-up Store (G/F, LANDMARK ATRIUM - Until 29 October)</li><li style="margin-left: 15px;">Central MTR Exit (B/F, Near LANDMARK)</li><li style="margin-left: 15px;">The LANDMARK Tram Station (West Bridge, 2/F LANDMARK ATRIUM)</li><li style="margin-left: 15px;">THE CHATER (2/F, LANDMARK CHATER)</li><li style="margin-left: 15px;">BaseHall 01 (LG/F, Jardine House)</li><li style="margin-left: 15px;">Frenchies (1/F, LANDMARK PRINCE&#039;S)</li><li style="margin-left: 15px;">HSBC Main Building (LG/F,&nbsp;<a href="https://www.google.com/maps/search/1+Queen&#039;s+Road+Central?entry=gmail&source=g" data-saferedirecturl="https://www.google.com/url?q=https://www.google.com/maps/search/1%2BQueen&#039;s%2BRoad%2BCentral?entry%3Dgmail%26source%3Dg&source=gmail&ust=1791689832516000&usg=AOvVaw0ah16_A38Urs0TthI6XrMW" style="color: rgb(17, 85, 204);">1 Queen&#039;s Road Central</a>&nbsp;? Until 7 October)</li><li style="margin-left: 15px;">The Plaza LKF Lobby (<a href="https://www.google.com/maps/search/21+D&#039;Aguilar+Street,+Central?entry=gmail&source=g" data-saferedirecturl="https://www.google.com/url?q=https://www.google.com/maps/search/21%2BD&#039;Aguilar%2BStreet,%2BCentral?entry%3Dgmail%26source%3Dg&source=gmail&ust=1791689832516000&usg=AOvVaw1oPSUVrkOF7j8YFMcjkiqn" style="color: rgb(17, 85, 204);">21 D&#039;Aguilar Street, Central</a>)</li></ul></td></tr></tbody></table><br style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px;"><br style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px;"><b style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px;"><u>Other Destination CENTRAL Activities At A Glance</u></b><span style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px;"></span><br style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px;"><br style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px;"><table style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px; background-color: rgb(255, 255, 255); width: 550px; border: 1px solid rgb(0, 0, 0); overflow: revert;"><tbody><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;"><b>Experiences & Highlights</b><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Dates<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;"><b>Locations</b><br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td colspan="3" style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;"><b>Inside LANDMARK</b><br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Destination CENTRAL Redemption Counter<br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">28 September 2026 - 28 February 2027<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">2/F LANDMARK ATRIUM<br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">The LANDMARK Tram Station & The Heritage Route<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">28 September 2026 - 18 November 2026<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">West Bridge, 2/F LANDMARK ATRIUM<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Destination CENTRAL Photo Booth<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">28 September 2026 - 28 February 2027<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">3/F Edinburgh Tower<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">THE CHATER<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">From 6 October onwards<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">2/F LANDMARK CHATER<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Platform 1889<br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Late October<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">2/F LANDMARK CHATER<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td colspan="3" style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;"><b>Louis Vuitton At LANDMARK</b><br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Louis Vuitton Pop-up Store<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">11 September - 29 October<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">G/F LANDMARK ATRIUM<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Louis Vuitton Mega Art Installation<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Late October<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">G/F LANDMARK ATRIUM<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Louis Vuitton Basement Exhibition<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Late October<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">B/F LANDMARK ATRIUM<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td colspan="3" style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;"><b>Halloween In Central</b><br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Central Halloween Takeover<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">17 October - 31 October<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Statue Square Gardens, South<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Boo-st Your Mood - Pickleball Day<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">17 October<br>2:00pm - 6:00pm<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Chater Road<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">OPEN By HE.R- Halloween In Central Kick-off Party<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">18 October<br>3:00pm - 10:00pm<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Chater Road<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Monster Mash Fest - Family Day<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">24 October<br>12:00pm - 9:00pm<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Chater Road<br><br></td></tr><tr style="margin: 6px; border: 1px solid rgb(0, 0, 0);"><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Halloween Night Unleashed<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">31 October - 1 November<br><br>2:00pm - 1:00am<br><br></td><td style="margin: 0px; border: 1px solid rgb(0, 0, 0); padding: 6px; vertical-align: top;">Chater Road<br></td></tr></tbody></table><br style="color: rgb(19, 19, 19); font-family: arial, "helvetica neue", helvetica, "Microsoft Yahei", "Microsoft JhengHei", sans-serif; font-size: 15px;"></div><div><br></div><div><div>Destination CENTRAL Redemption Gifts</div><div>66,000 Asia Miles-equivalent to one Cathay Pacific Business Class round-trip ticket to Japan*</div><div>26,000 Asia Miles-equivalent to one Cathay Pacific Economy Class round-trip ticket to Japan*</div><div>Destination CENTRAL Tram Plush Charm</div><div>Destination CENTRAL Magnet</div><div>Destination CENTRAL Photobooth Experience</div><div>Destination CENTRAL Mini Camera</div><div>Ami Signature Beef Sando</div><div>BaseHall HK$50 Gift Certificate</div><div>THE CHATER HK$50 Gift Certificate</div><div><br></div><div>*Based on Cathay Flight Awards ? Standard Awards as of 1 September 2026. Terms and conditions apply.</div><div><br></div><div>About LANDMARK</div><div>LANDMARK represents the epitome of top-tier luxury shopping and lifestyle experiences. Drawing from a rich heritage which began in 1904 ? LANDMARK today is the luxury shopping destination of Hongkong Land&#039;s Central portfolio including 4 iconic connected buildings, LANDMARK ATRIUM, LANDMARK ALEXANDRA, LANDMARK CHATER and LANDMARK PRINCE&#039;S. LANDMARK offers approximately 208 of the finest stores and restaurants, all seamlessly linked by pedestrian bridges. From high fashion and accessories to watches and jewellery, from luxury living to beauty and grooming, from international cuisine to authentic gourmet dining, LANDMARK brings the ultimate shopping experience to the discerning customer.</div><div><br></div><div>About Hongkong Land</div><div>Hongkong Land is a major listed property investment, management and development group. The Group focuses on developing, owning and managing ultra-premium mixed-use real estate in Asian gateway cities, featuring Grade A office, luxury retail, residential and hospitality products. Its mixed-use real estate footprint spans more than 850,000 sq. m., with flagship projects in Hong Kong, Singapore and Shanghai. Its properties hold industry leading green building certifications and attract the world&#039;s foremost companies and luxury brands. The Group&#039;s Hong Kong Central portfolio represents some 450,000 sq. m. of prime property.</div><div><br></div><div> The Group has a further 165,000 sq. m. of prestigious office space in Singapore mainly held through joint ventures and five retail centres on the Chinese mainland, including a luxury retail centre at Wangfujing in Beijing. In Shanghai, the Group owns a 43% interest in a 1.1 million sq. m. mixed-use project in West Bund, which is due to be completed in 2028. Hongkong Land Holdings Limited is incorporated in Bermuda and has a primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. Hongkong Land is a member of the Jardine Matheson Group.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #LANDMARKHK</div><div><br></div></div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 11:04:00 +0700</pubDate>
</item>
<item>
<title>*Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA (Olanzapine) For .....................</title>
<link>https://relleaseid.com/berita-bisnis/-Teva-Announces-U-S--Food-and-Drug-Administration--FDA--Approval-of-WELTRUZA--Olanzapine--For----------------------</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/596_-Teva-Announces-U-S--Food-and-Drug-Administration--FDA--Approval-of-WELTRUZA--Olanzapine--For----------------------.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div><h3 align="center" style="font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; color: rgb(0, 0, 0);"><div style="font-size: 13px; text-align: start;">*Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia</div></h3><ul type="disc"><li>WELTRUZA?&nbsp;(olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous long-acting injectable (LAI) formulation of olanzapine for the treatment of schizophrenia in adults with no loading doses, no oral supplementation and no post-injection monitoring required</li><li>The approval is based on results from the pivotal Phase 3 SOLARIS trial, which demonstrated overall symptom improvement, significant reduction in illness severity and improvement in personal and social functioning, with a systemic safety profile consistent with oral olanzapine1</li><li>As Teva drives forward its Pivot to Growth strategy, the company continues to deliver on its commitment to patient-centered innovation in neuroscience, including a differentiated long-acting injectable franchise<br><br></li></ul><p align="center">Teva will hold an investor call and live webcast on Friday, October 9, 2026, 8:00 a.m. ET</p><p align="left">PARSIPPANY, N.J. and TEL AVIV, Israel, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved WELTRUZA?&nbsp;(olanzapine) for extended-release injectable suspension, a new, once-monthly, subcutaneous long-acting injectable (LAI) for the treatment of schizophrenia in adults. WELTRUZA clinical trial results demonstrated improvement in symptoms (PANSS), significant reduction in illness severity (CGI-S), as well as improvement in personal and social functioning (PSP).1&nbsp;In the coming weeks, WELTRUZA will be available in three different strengths (318 mg, 425 mg, 531 mg) with no loading doses, no oral supplementation and no post-injection monitoring required.1</p><p><a data-type="gnw-snippetgallery" href="https://www.globenewswire.com/Tracker?data=G6wG1C5AZzDHlsB2NAtpbMxCYKE7g1_pgCV9VVfkqnoRvOFgzY1nUlGBL5VQAxRZwOEhMEq4e8db-VST98UNMAtsXvTmyi_O1EvFoMTp5du_kzOETgr_b7S_SOUvbb7a" rel="nofollow" target="_blank"><img alt="Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA? (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzap: Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA? (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia" data-mce-style="display: block; margin-left: auto; margin-right: auto;" src="https://ml-eu.globenewswire.com/Resource/Download/8abc40f6-d8a4-4ad2-8891-c9cb8787adaf/weltruza-logo-1.png" data-dpi="300" data-caption="WELTRUZA Logo 2" data-filename="WELTRUZA Logo 1.png" style="display: block; margin-left: auto; margin-right: auto;"></a></p><p align="center"><a href="https://www.globenewswire.com/Tracker?data=4eeBRTe_DaMPecxVp60VbpPPtYmz54aOLBD9RKEUsLvRlppbbcgdiSxVJ1arkZpO8IZQqkH5qBOo3f1ufdSg0M9AQx3km6T_Vouof_-_1qJw3yzThfsws63ZYn2yHmwG3AYSJ90XC_dScYFo7Bhhj5XJHIt2vLEcquS_oEFyuRwJ03BuScJXCUziDseE_zG4" rel="nofollow" target="_blank">A suite of downloadable multimedia assets is available here.</a></p><p>"WELTRUZA offers the proven efficacy of olanzapine in an innovative long-acting subcutaneous injectable, helping to fill a major, long-standing gap in the schizophrenia treatment landscape," said Chris Fox, Executive Vice President, U.S. Commercial and Head of Innovative Franchise at Teva. "WELTRUZA was developed with the patient in mind from day one and it is a powerful demonstration of what is possible when the needs of the patient guide the development of a truly innovative medicine. This important milestone also helps further Teva&#039;s Pivot to Growth strategy."</p><p>Olanzapine is the most widely prescribed atypical antipsychotic for schizophrenia as a daily oral treatment.2&nbsp;However, it is well documented that daily options may make it difficult to sustain long-term symptom improvement due to challenges with adherence, increasing the risk for instability and relapse.1&nbsp;WELTRUZA was developed to address this significant unmet need by offering the established efficacy of olanzapine in a once-monthly subcutaneous injectable formulation.1</p><p>"This approval reflects the strength of patient-centric innovation at Teva and what our R&D organization can deliver," said Eric Hughes, MD, PhD, Executive Vice President, Global R&D and Chief Medical Officer at Teva. "WELTRUZA combines proven science and novel formulation innovation to eliminate the need for monitoring after each injection, addressing a significant barrier to treatment and advancing care for people living with schizophrenia."</p><p>WELTRUZA will be available in once-monthly subcutaneous injectable doses of 318 mg, 425 mg and 531 mg that correspond to the approved daily dose range of oral olanzapine of 10 mg, 15 mg and 20 mg, respectively.1</p><p>"Olanzapine has been a trusted and foundational treatment option for people living with schizophrenia for more than 30 years, but adherence continues to be a major barrier to stability, particularly for those who rely on daily oral medications," said Christoph Correll, MD, Clinical Professor of Psychiatry at the Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY. "By offering a subcutaneous long-acting injectable formulation with achievement of therapeutic blood levels without oral cotreatment, loading doses or booster injections, this new treatment option can help empower patients, support their care partners and provide clinicians with an important new tool to assist in managing this complex condition more effectively."</p><p>In the Phase 3 SOLARIS trial, all three doses of WELTRUZA were similarly tolerated, with the most common reported adverse events (AEs) inclusive of increased weight, somnolence, headache, constipation and injection site reactions.1&nbsp;Weight gain and metabolic changes were observed and were consistent with the systemic safety profile of oral olanzapine, including clinically significant weight gain.1&nbsp;Discontinuations of WELTRUZA due to common AEs were consistent with placebo at 5% and 4% of trial participants, respectively.1&nbsp;Please refer to the Important Safety Information below for additional safety information.</p><p>An estimated 2.1 million people are currently diagnosed with schizophrenia in the U.S. It is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and behaves.3&nbsp;Schizophrenia is a complex medical condition that may require switching from oral options or between long-acting injectable options during the treatment journey.</p><p>WELTRUZA utilizes SteadyTeq?, a copolymer technology proprietary to Medincell that provides a controlled steady, sustained release of olanzapine.</p><p>WELTRUZA will be available in the U.S. in the coming weeks.</p><p>The European Medicines Agency (EMA) accepted the Marketing Authorization Application (MAA) for olanzapine long-acting injectable (TEV-&#039749) for the treatment of schizophrenia in adults in May 2026. The EMA submission is supported by an extensive clinical development program, including the Phase 3 SOLARIS study. TEV-&#039749 is not approved by the EMA at this time.</p><p>Teva Investor Call<br>Teva will hold an investor call and live webcast tomorrow, Friday, October 9, 2026, at 8:00 a.m. ET/ 2:00 p.m. CET. To participate, please register in advance&nbsp;<a href="https://www.globenewswire.com/Tracker?data=X8RNYwvvYGls32bh0_JlIxw6cLlYXFKMztMFFxH07nJuiA81UWz2KVjtx7UZxxRFb1iPGz1pQ8Kxtgp-cBcphGN432_brlOwO-FcOOj_gdqzE9tH2e1AaVINHvsjfUhp4bgHbt3-vpUNmlcBE5iSYgiyMe3Y8OEp2wLustD9GMnRXLW0_i7JwCY2inX_T4T0n9QBls5m-6T-3NitewmlaC733Alu2UHGCTVgdbI6Y_j74_95bBXxQ4RqMBWmNad0gSlr5m92MAxMDuiz1P-txmcrEY3DYVw9rzcjRHFoX5vQIGddGykvs_dk-243cWQDLe_r68jSsL8Jz5odYI5rbEzFX-jyGVYNeJ9d5vTYBcOg8E2fv-jvrTydfayZ4D90RK9o6C11heozcejTqtCZVRV239-2FPXSOtPk6RSQMTodZdPzTolBU94Ff6a0v5f-U7hsRZxLsutSlM_nELcZVU4hP0NebU8gyB34ph1xrcdmclNqcYN-O9tgQgIb6iQpOpwk44FLny7jROIg2Mu_Zh-Kdrd56gnx3f901MfrnQMwRQ30s2iDYQwi6fSRg4m1pVNdoY5nZlscIk4LbtVWsIld1KJ0KWSNguZp6tqQHsMSdL0ZL56Nx8yxPlHVIMONh30ufrDLVNCZpl24XL7gWQvKm6IpEvEqebWLHFsbLr-TkC7rDeF0oPMfmHcXuQSj747sfW47UbXHuLhmDUcx2XwI_7GFyTI4a_N5G3L31KlFiMyQpCNHEBh6wR5TBBWTpYjFtfkWFK7VKHAexcUD9qrHJFlpkvLlPedHpMk8xPZMfEsgWe4vOG3OJfnVand1BbKlo1jU8r5tudb6MGAciMizEI-T53KmfqhbMgvST94FZmDW2f1Tfe7J_0_NoA7MswXtxnFwgDmHEGUucKKKiU8_kAxRs5Jzk2GbhC29Y1fl121aZL6d_VDYXC9mk_b6OUNkSKkhOtsqIT-dCtX6J3BHv1ckMqmkc2MKLlDyvhLllXfaIT5LMDWTV1Di5Nobc_gSzOowR2MbCh9RbHpRsKF1oMIh5nMrwwQU3FpDtwWVbxuKgX89e1cxpSGk1zmUwoYAWExgnD1EBH6yyt_8GCpttYBOf4dO_OHgSIp_BHSaYIaDxUzP5SlaTlb_d835XmVrJqopYyf7I_Grvvhk759wGzKjtAmcVhQETeD7wCKjla5mHo3UCaBH0QtCRZZtst6sQOMIveMHGmB-cVRwV7DbrC80__wXqmsUao3saxyf6sRSutVB7jQhCbG6yOYrdDhkE5UuVwB_jDmeVNC7kEACRkjH4ufsIyJlXN9k3lNF4R9iL02CjK7HKw04sxWhr1e41gOsCjsB1xe5KqBNTJW7GYz2RZ-mOapxX7mk5zk=" rel="nofollow" target="_blank">here</a>. To access a live webcast of the presentation, visit&nbsp;<a href="https://www.globenewswire.com/Tracker?data=gkOBFI1d22mcQaHnkKCNkO9sx7Iz9sNm6VCqUppIkST60aO85AsxgE-2lCH1ToNpU-Q2sbgaoeWyBE7rVzjbsIi4BDSd4jvjYl6WSitQOXeSDxHw84hNgSTgTiDiEWWOT0vB07OePerQSiL2etvHWgqWE8R9PzB2K6KVx-nkQqxttzqxodIzuOMlC_2KH35GwHv6l5BDmji6cCWD4zlXUnMrSadj6dRR0crbIy-NsNSbmUhWfXXyN1xC57_nDb3-iOBSB5SQPQB1hCeLPDuHkUtNR_1fjRd1Kgfg8tq2gdln2ja8wvOkLKV8S80HO0ogNQUq9LXJedvfCCMuH8O5iQr6WyV9VIfk63gAjPX3-AxfFiB0SMwbgzpJYGKViYW_RS0y5fasrShET5Kx_E1g2nzx0D0wvA71JNnFOh7nEeWK9CxetQ8zSilWnpN4C0pfEcgnybwy59yiquHd9LVe5WblD9Tx84KT99XlvYXR7N4dGDGZvU01Hm8K21ObYjQJGeXcw24vBG7NtwScRjhb0SEiE12tcYwltic32zWv33XZr9C6wXwvJsnsY0d4yM2W42UA8f3XxJh5foavffWa2ygb7-nau6NQWP1oqthnWwBkXWqLAgI1mPV6frS8Wm-AeeAnkO-i5zd9GNEuUnD1fGFLOohPX2fh8O8-rj5WvnXlA48lHVg2CHMzHTMOeEnd2JS_UKFXaVwIYlJzbU2JI6EtSvgzTb93IzAUv2B-J-RKK6WiszougnzeABbaSTfy47evepIsdfh0XmvdpofGxodUu0PQWPfvwq5X3FQGq3apucxqQqJOr-hr3chJ-2NOxfW6OYO_6J-jd1sgvySTLAmYKQKY_1CwDtCVAYbZPLT4NrJ8aOA5joHu-1VXza4w3MTEWML_ymh9Kr1pRlU8sueDSFhP6TgDc48HKJFAhOfwXes0T4XeBQvcnCIhv5P6564orBNJptLSrFsHdu-20UtVXh8Eg3ehC2Iq2nJAi6GZ517gh45G8BYt62Us1dQ5xpOikzzVnKoseBkJJoX3LYXo6HANpSjHScDFtnwlD08gMYz5UQgD7K4PSAgku8r6" rel="nofollow" target="_blank">Teva&#039;s Investor Relations website</a>. An archived version of the webcast will be available 24 hours after the end of the live discussion.</p><p>APPROVED USE</p><p>WELTRUZA?&nbsp;(olanzapine) for extended-release injectable suspension is a prescription medicine used in adults for the treatment of schizophrenia.</p><p>IMPORTANT SAFETY INFORMATION</p><p>What is the most important information I should know about WELTRUZA?</p><p>WELTRUZA can cause serious side effects, including an increased risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). WELTRUZA is not for the treatment of people with dementia-related psychosis.</p><p>WELTRUZA may cause serious side effects, including:</p><ul type="disc"><li style="margin-bottom: 8pt;">Post-injection delirium/sedation syndrome (PDSS)&nbsp;is a serious problem that can happen when too much olanzapine enters the bloodstream too quickly. PDSS has happened in people who received another extended-release olanzapine medicine by injection into their muscles (intramuscularly). WELTRUZA is injected under the skin (subcutaneously). It is not known whether PDSS can happen with WELTRUZA. PDSS with an extended-release intramuscular injection has led to hospitalization, has happened within the first 3 hours of injection, but also happened after 3 hours of injection, and has the risk each time an injection is received. Tell your healthcare provider right away or go to the nearest emergency room if you get signs or symptoms of PDSS, including more sleepiness than usual, dizziness, confusion or disorientation, trouble walking or talking, stiff muscles or shakiness, weakness, feeling grouchy or angry, feeling anxious or nervous, increased blood pressure, seizures (convulsions), or passing out.</li><li style="margin-bottom: 8pt;">Strokes in elderly people (cerebral problems) that can lead to death.</li><li style="margin-top: 6pt; margin-bottom: 6pt;">Neuroleptic Malignant Syndrome (NMS). NMS is a serious condition that can lead to death. Seek medical attention right away&nbsp;if you have any of these symptoms: high fever, stiff muscles, confusion, changes in pulse, heart rate, or blood pressure, increased sweating.</li><li style="margin-top: 6pt; margin-bottom: 6pt;">Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).&nbsp;DRESS is an allergic reaction that can cause death that may affect your skin or other parts of your body including your liver, kidney, lungs, or heart. Contact your healthcare provider right away if you experience any signs or symptoms of DRESS, including fever, skin rash or blistering or peeling skin, swelling of face, glands, or other body parts, cough or trouble breathing, chest pain, yellowing of the skin or eyes, dark urine or changes in urination.</li><li style="margin-top: 6pt; margin-bottom: 6pt;">Problems with your metabolism&nbsp;that may include high blood sugar (hyperglycemia), diabetes mellitus, changes in the fat levels in your blood (dyslipidemia), and weight gain. Extremely high blood sugar can lead to coma or death. If you have diabetes or are at risk of diabetes (e.g., obesity, family history of diabetes), your healthcare provider should check your blood sugar before you start and during treatment with WELTRUZA. Call your healthcare provider if you have symptoms of high blood sugar, including feeling very thirsty, hungry, sick to your stomach, weak or tired, or confused; needing to urinate more than usual; or your breath smells fruity.</li><li style="margin-top: 6pt; margin-bottom: 6pt;">Uncontrolled facial or body movements (tardive dyskinesia)&nbsp;that may not go away, even if you stop receiving WELTRUZA. Tell your healthcare provider if you get any body movements that you cannot control.</li><li style="margin-bottom: 8pt;">Decreased blood pressure (orthostatic hypotension).&nbsp;You may feel dizzy or lightheaded, get a fast or slow heartbeat, or faint, when you rise too quickly from a sitting or lying position.&nbsp;Drinking alcohol and using other medicines that make you dizzy can increase your risk for orthostatic hypotension. Avoid drinking alcohol during treatment with WELTRUZA.</li><li style="margin-bottom: 8pt;">Falls.&nbsp;WELTRUZA may make you sleepy or dizzy, may cause a decrease in your blood pressure when changing position (orthostatic hypotension), and can slow your thinking and motor skills which may lead to falls that can cause fractures or other injuries.</li><li style="margin-bottom: 8pt;">Low white blood cell counts.&nbsp;Your healthcare provider may do white blood cell count tests during your first few months of treatment with WELTRUZA.</li><li style="margin-bottom: 8pt;">Difficulty swallowing that can cause food or liquid to get into your lungs.</li><li style="margin-bottom: 8pt;">Seizures (convulsions).</li><li style="margin-bottom: 8pt;">Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities.&nbsp;Do not drive, operate machinery, or do other dangerous activities until you know how WELTRUZA affects you.</li><li style="margin-bottom: 8pt;">Problems controlling your body temperature so that you feel too warm.&nbsp;Avoid getting overheated or dehydrated.</li><li style="margin-bottom: 8pt;">Certain side effects from the way WELTRUZA works in your body&nbsp;such as constipation, dry mouth, fast heartbeat, urinary retention, or prostate and bowel problems. Your risk is increased if you take other medicines that also cause these side effects.</li><li style="margin-bottom: 8pt;">Increased prolactin levels in your blood (hyperprolactinemia).&nbsp;WELTRUZA can cause a rise in the blood levels of a hormone called prolactin that may cause side effects including missed menstrual periods, a reversible reduction in fertility in females who are able to become pregnant, leakage of milk from the breasts, development of breasts in men, or problems with erection.<br><br></li></ul><p>The most common side effects of olanzapine in patients with schizophrenia&nbsp;include weight gain, sleepiness, headache, and constipation. Injection site reactions, including hardness, pain, redness, itching, and swelling, were reported with WELTRUZA.</p><p>These are not all the possible side effects with WELTRUZA. Tell your healthcare provider if you have any side effect that does not go away. For more information, ask your healthcare provider or pharmacist.</p><p>Before receiving WELTRUZA, tell your healthcare provider about all of your medical conditions, including if you:</p><ul type="disc"><li style="margin-bottom: 8pt;">have or had diabetes or high blood sugar</li><li style="margin-bottom: 8pt;">have or had high levels of total cholesterol, LDL cholesterol, or triglycerides, or low HDL levels in your blood</li><li style="margin-bottom: 8pt;">have or had low or high blood pressure</li><li style="margin-bottom: 8pt;">have or had heart problems or stroke</li><li style="margin-bottom: 8pt;">are dehydrated</li><li style="margin-bottom: 8pt;">have or had a low white blood cell count</li><li style="margin-bottom: 8pt;">have or had seizures (convulsions)</li><li style="margin-bottom: 8pt;">have or had problems with urination or prostate problems</li><li style="margin-bottom: 8pt;">have Alzheimer&#039;s disease</li><li style="margin-bottom: 8pt;">have or had constipation or bowel obstruction</li><li style="margin-bottom: 8pt;">have or had breast cancer</li><li style="margin-bottom: 8pt;">are pregnant or plan to become pregnant. WELTRUZA may harm your unborn baby.&nbsp;Receiving WELTRUZA during your third trimester of pregnancy may cause your baby to have abnormal muscle movements or withdrawal symptoms such as agitation, stiffness or floppiness, tremors, sleepiness, and breathing or feeding problems after birth.&nbsp;Talk to your healthcare provider about the risks to your baby if you receive WELTRUZA during pregnancy.<ul type="circle"><li>If you become pregnant during treatment with WELTRUZA, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics. You can register by calling 1-866-961-2388 or go to&nbsp;<a href="http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/" rel="nofollow" target="_blank">http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/</a>.</li></ul></li><li style="margin-bottom: 8pt;">are breastfeeding or plan to breastfeed. WELTRUZA passes into breast milk. If you breastfeed during treatment with WELTRUZA, tell your healthcare provider if your baby is very sleepy, irritable, is feeding poorly, or gets tremors or abnormal muscle movements. Talk to your healthcare provider about the best way to feed your baby during treatment with WELTRUZA.<br><br></li></ul><p>Tell your healthcare provider about all the medicines you take or plan to take,&nbsp;including prescription and over-the-counter medicines, vitamins, and herbal supplements.&nbsp;Especially tell your healthcare provider if you take:&nbsp;blood pressure medicines, levodopa or dopamine, or other olanzapine medicines. Your healthcare provider can tell you if it is safe to receive WELTRUZA with your other medicines.</p><p>Do not&nbsp;start or stop any medicines during treatment with WELTRUZA without talking to your healthcare provider first.&nbsp;</p><p>You are encouraged to report side effects of prescription drugs to the FDA. Visit&nbsp;<a href="https://www.globenewswire.com/Tracker?data=C7FgBK9DqdiwjqBiKvU84a3joVsJZR37_U589tHGvyIOlXgL8HZY8Gdnx5mgCr1c2dTX8J6KK4lnCOMY9orW37n6FsuJT5moJdsicbF0vDY=" rel="nofollow" target="_blank">www.fda.gov/medwatch</a>,&nbsp;or call&nbsp;1-800-FDA-1088.</p><p>For more information about WELTRUZA, see the full&nbsp;<a href="https://www.globenewswire.com/Tracker?data=AXE0bHX9rggrFF2uMSv0a6xLkoQpioSvKm_IscQIy1OBQklnVJeIcRNDnzH1Bf1AgJ2tYB032tSESRkL9STNVaJLY_UxkToERq-dKOle0b9o_VRoZ2YoYkIg8LBtUdH5wxOW864vImjuYzIzn0oN_tTIkiqh9WhDNM4YmQZcfajMo667iBnUQiqw0tlY2v9KHfzFsqD7ceNilTZ7V360jA==" rel="nofollow" target="_blank">Prescribing Information, including Medication Guide</a>&nbsp;and Boxed WARNING, or talk to your healthcare provider.</p><p>About Subcutaneous Olanzapine Extended-Release Injection Study (SOLARIS)<br>SOLARIS was an 8 week, multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of olanzapine extended-release injectable suspension for subcutaneous use as a treatment in patients (ages 18-64 years) with schizophrenia.1&nbsp;For period one of the study (first 8 weeks), 675 patients were randomized to receive a subcutaneous injection of once-monthly olanzapine LAI (WELTRUZA) (low, medium or high dose) or placebo in a 1:1:1:1 ratio.1&nbsp;For period two (next 48 weeks), patients who completed period one on placebo were re-randomized and equally allocated to one of the three olanzapine LAI (WELTRUZA) treatment groups, while patients who completed period one on active olanzapine LAI (WELTRUZA) remained on their established dose strength.1&nbsp;The end-of-treatment and follow-up visits were 4 and 8 weeks after administration of the last treatment dose, respectively.1&nbsp;The primary objective of the Phase 3 SOLARIS study was to evaluate the efficacy of olanzapine LAI (WELTRUZA) in adult patients with schizophrenia, as measured by PANSS.1&nbsp;A key secondary objective was to further evaluate the efficacy of olanzapine LAI (WELTRUZA) based on additional parameters in adult patients with schizophrenia, as measured by CGI-S and PSP.1&nbsp;A secondary objective of period two of the study was to evaluate the safety and tolerability of olanzapine LAI (WELTRUZA) in adult patients with schizophrenia.1</p><p>About Schizophrenia<br>Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts.4&nbsp;Patients experience an array of symptoms, which may include delusions, hallucinations, disorganized speech or behavior and impaired cognitive ability.4,5,6&nbsp;Approximately 1% of the world&#039;s population will develop schizophrenia in their lifetime, and 2.1 million people in the U.S. are currently diagnosed with the condition.3,4,5&nbsp;Although schizophrenia can occur at any age, the average age of onset tends to be in the late teens to the early 20s for men and the late 20s to early 30s for women.4&nbsp;The long-term course of schizophrenia is marked by episodes of partial or full remission broken by relapses that often occur in the context of psychiatric emergency and require hospitalization.6&nbsp;Approximately 80% of patients experience multiple relapses over the first five years of treatment, and each relapse carries a biological risk of loss of function, treatment refractoriness and changes in brain morphology.7,8,9&nbsp;Patients are often unaware of their illness and its consequences, contributing to treatment nonadherence, high discontinuation rates and, ultimately, significant direct and indirect healthcare costs from subsequent relapses and hospitalizations.4,5,6,7,8,9</p><p>About Teva<br>Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva&#039;s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients&#039; needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit&nbsp;<a href="https://www.globenewswire.com/Tracker?data=C7FgBK9DqdiwjqBiKvU84SEiYRaJu8e0YCNTrwEWf1YPHqCYV9LF4ucBjlpesjJXs8UtA3LSMdRsxAQ2wzuBQlrBuZGRvDRkISaRvufkLlY=" rel="nofollow" target="_blank">www.tevapharm.com.</a></p><p>Cautionary Note Regarding Forward-Looking Statements<br>This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management&#039;s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as "should," "expect," "anticipate," "estimate," "target," "may," "project," "intend," "plan," "believe" and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully develop and commercialize WELTRUZA for the treatment of schizophrenia in adults; our ability to successfully compete in the marketplace, including our ability to develop and commercialize additional pharmaceutical products; our ability to successfully execute on our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and to profitably commercialize our innovative medicines and biosimilar portfolio, whether organically or through business development; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; financial, economic and other risks; and other factors discussed in our Quarterly Report on Form 10-Q for the second quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned "Risk Factors" and "Other Information." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.</p><ol><li>Data on file. [CSR/SOLARIS]. West Chester, PA: Teva Neuroscience, Inc.</li><li>Data on file. [TRx data sourced from IQVIA NPA Full Year 2025; orals factored for SCZ using Analytics Link 2022.] Parsippany, NJ: Teva Neuroscience, Inc.</li><li>Data on file. [DRG/Clarivate (Nov 2025 Market Forecast Assumptions-Schizophrenia)]. Parsippany, NJ: Teva Neuroscience, Inc.</li><li>Substance Abuse and Mental Health Services Administration. Schizophrenia.&nbsp;<a href="https://www.samhsa.gov/mental-health/schizophrenia" rel="nofollow" target="_blank">https://www.samhsa.gov/mental-health/schizophrenia</a>. Accessed February 2026.</li><li>Velligan DI, Rao S. The Epidemiology and Global Burden of Schizophrenia. J Clin Psychiatry. 2023;84(1):MS21078COM5. https://doi.org/10.4088/JCP.MS21078COM5.</li><li>Wander C. (2020). Schizophrenia: Opportunities to Improve Outcomes and Reduce Economic Burden Through Managed Care. The Am J Manag Care. 26(3 Suppl), S62?S68. https://doi.org/10.37765/ajmc.2020.43013.</li><li>Emsley, R., & Kilian, S. (2018). Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review. Neuropsychiatric Dis. Treat., 14, 205?223.</li><li>Emsley, R., Chiliza, B., Asmal, L. et al. (2013) The nature of relapse in schizophrenia. BMC Psychiatry 13, 50.</li><li>Andreasen, N. C., et al. (2013). Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. The Am J Psychiatry, 170(6), 609?615.<br><br></li></ol><p>Teva Media Inquiries:<br><a href="https://www.globenewswire.com/Tracker?data=gkOBFI1d22mcQaHnkKCNkFeXQZrVadq94IlSUrA_2DxjKIc_KXIVvWA2Ca4BLsMcjCDOQ2bikc09j1QYKOgcYXvfPcT6CXPcQLsPoj_hDqOrTeL-WZ0rsaW-1bAjVDmTwQD7dCFTMkRsxtvTCyaWzLcXLn5ofvncovLGzMSAueE=" rel="nofollow" target="_blank">TevaCommunicationsNorthAmerica@tevapharm.com</a>&nbsp;<br>Teva Investor Relations Inquiries:<br><a href="https://www.globenewswire.com/Tracker?data=gkOBFI1d22mcQaHnkKCNkAUaYy0l43B3tjq3biB_BvFfFFvdr7z_N2F6RHE52qj5Tv4T4Ubb0O3BiKqL6AriBFcvmrGcrL3aKQyg3CXWFoI=" rel="nofollow" target="_blank">TevaIR@Tevapharm.com</a></p><img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTI3NzA3NCM0MDI1MjE4OTYjMjAwMzA3Nw=="><br><img alt="" src="https://ml-eu.globenewswire.com/media/NmNhOWYxMTItZWJkNS00YmE4LTk4NzQtMGU1MGY3ODFlYmFiLTEwMTQ2NTAtMjAyNi0xMC0wOS1lbg==/tiny/Teva-Pharmaceutical-Industries.png" referrerpolicy="no-referrer-when-downgrade"><p align="center">Copyright 2026 GlobeNewswire, Inc.</p></div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 10:55:00 +0700</pubDate>
</item>
<item>
<title>Yacht Club de Monaco&#039;s Tuiga wins at Saint-Tropez</title>
<link>https://relleaseid.com/berita-bisnis/Yacht-Club-de-Monaco--039-s-Tuiga-wins-at-Saint-Tropez</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/3805_Yacht-Club-de-Monaco--039-s-Tuiga-wins-at-Saint-Tropez.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>MONACO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Tuiga has claimed victory at Les Voiles de Saint-Tropez. 2026 is a historic year for the gaff-rigged cutter of the Yacht Club de Monaco. Fresh from a voyage along the east coast of the United States, Tuiga (1909) triumphed in the Tradition class at the 28th edition of the annual regatta held in the Gulf of Saint-Tropez.</div><div><br></div><div>Tuiga was skippered by Yacht Club de Monaco Vice-President Pierre Casiraghi, alongside a high-calibre crew bringing together experience from the America&#039;s Cup, ocean racing and the Olympic Games. Also on board were two-time America&#039;s Cup winner Jimmy Spithill, German sailor Boris Herrmann of Team Malizia and, during the final stage, Loick Peyron. </div><div><br></div><div>The crew also included Dutch sailor Rosalin Kuiper, who competed in The Ocean Race with Team Malizia; British sailor Tom Dawson, a veteran of the Extreme Sailing Series and an Admiral&#039;s Cup winner alongside Casiraghi; Italian sailor Lorenzo De Felice, a Moth and foiling specialist; and French freediver Arnaud Jerald, holder of several world records.</div><div><br></div><div>"With Boris navigating, Lo?ck handling tactics and Jimmy at the helm, we could not have asked for anything better. What a crew, what a week," Casiraghi said, also highlighting the presence on board of several Club members and young sailor Louise Debeaumont, competing on Tuiga for the first time.</div><div><br></div><div>The Monegasque cutter remained among the leading boats throughout the week. On Tuesday, with an easterly breeze and gusts exceeding 15 knots, Tuiga finished second. The same result followed on Wednesday, keeping the boat firmly in contention for victory. On Thursday, in the Centenary Trophy, a pursuit race, Kismet crossed the finish line ahead of Tuiga to claim the trophy. On Friday, with moderate easterly winds, the Monegasque cutter maintained its pace ahead of the final day.</div><div><br></div><div>On Saturday, the crew completed the course with maximum concentration, finishing the week at the top of the overall standings and securing victory in its class.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 10:49:00 +0700</pubDate>
</item>
<item>
<title>Arla Foods Ingredients showcases personalised clear shake innovation at SupplySide Global</title>
<link>https://relleaseid.com/berita-bisnis/Arla-Foods-Ingredients-showcases-personalised-clear-shake-innovation-at-SupplySide-Global</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4741_Arla-Foods-Ingredients-showcases-personalised-clear-shake-innovation-at-SupplySide-Global.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>COPENHAGEN, Denmark, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Arla Foods Ingredients will demonstrate three new personalised clear shake solutions offering multiple benefits at SupplySide Global (28th-30th October in Las Vegas).&nbsp;</div><div><br></div><div>The concepts demonstrate how brands can move beyond "one-size-fits-all" protein shakes, creating protein solutions tailored for various performance scenarios and active lifestyles.&nbsp;</div><div><br></div><div>They meet the growing market demand for clear protein beverages, a lighter, fruitier, and more refreshing alternative to traditional milky protein shakes.&nbsp;&nbsp;</div><div><br></div><div>Combining high-quality Lacprodan whey proteins with selected functional ingredients, the three concepts are built around a shared recovery need and three distinct performance outcomes:&nbsp;</div><div><br></div><div>BUILD: A Resistance Shake with Lacprodan ISO.RefreshShake + creatine, tailored for strength and power-focused activities such as weightlifting, strength training and CrossFit.&nbsp;</div><div><br></div><div>SUSTAIN: An Endurance Shake with Lacprodan Pro2O + carbohydrates and electrolytes, tailored for endurance-focused activities such as running, cycling and endurance sports.&nbsp;</div><div><br></div><div>MOVE: A Mobility Shake with Lacprodan ISO.WaterShake + collagen for mobility-focused activities such as yoga, pilates, gymnastics and dance.&nbsp;</div><div><br></div><div>Peter Schouw Andersen, Senior Director, Performance Nutrition at Arla Foods Ingredients, said: "These new personalised clear shake concepts show how our clear whey protein isolates help brands create great-tasting solutions for different consumer needs and performance goals. Designed for a wide range of sports nutrition users, they deliver high-quality protein and functional benefits in a convenient format. From strength and power to endurance and hydration, mobility and flexibility, they demonstrate clear whey protein&#039;s versatility as a foundation for personalised sports nutrition."&nbsp;&nbsp;</div><div><br></div><div>Visitors to SupplySide Global can sample the personalised shake solutions at Booth #2945, alongside:&nbsp;</div><div><br></div><div>An aerated milk protein bar with a light texture, bringing a new sensory experience to protein bars. With nutrition and indulgence in an airy bite, AirBar features Nutrilac PB-8420, which delivers stable aeration and texture stability.&nbsp;</div><div><br></div><div>A high-protein, water-based shot for GLP-1 companion nutrition in a compact format designed for consumers with reduced appetite. Featuring Lacprodan BLG-100, it contains 21g protein per 100ml and is fat-free, sugar-free and low in lactose, offering great taste, minimal astringency and ambient shelf-life stability.&nbsp;</div><div><br></div><div>A sparkling, fruity protein soda combining the soft drink appeal with high-quality whey protein isolate. It&#039;s made with Lacprodan Pro2O, which enables clear, low-viscosity protein sodas with a clean taste, low astringency, and strong flavour expression, supporting stable, fruity, functional soft drinks with added protein.&nbsp;</div><div><br></div><div>hz@ispiderpr.com</div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Sat, 10 Oct 2026 10:39:00 +0700</pubDate>
</item>
<item>
<title>Sunway Medical Centre Damansara Marks New Chapter in Specialist and International Patient Care</title>
<link>https://relleaseid.com/berita-bisnis/Sunway-Medical-Centre-Damansara-Marks-New-Chapter-in-Specialist-and-International-Patient-Care</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/6410_Sunway-Medical-Centre-Damansara-Marks-New-Chapter-in-Specialist-and-International-Patient-Care.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 9 October 2026 - Sunway Medical Centre Damansara (SMCD), the fourth tertiary hospital under Sunway Healthcare Group (SHG), celebrated its Official Launch Ceremony on 1 October 2026, marking a significant milestone since commencing operations in December 2024.</div><div><br></div><div>Strategically located in Kota Damansara, SMCD serves communities across the Klang Valley, with a greater focus on the northern, northwestern and western regions. The hospital was established to bring high-quality specialist healthcare closer to these growing communities, while also serving local patients, expatriates and international health tourists seeking care in Malaysia.</div><div><br></div><div>Officiating the ceremony, the Chief Minister of Selangor YAB Dato&#039; Seri Amirudin bin Shari, said that the establishment of private hospitals such as SMCD supports the state&#039;s Rancangan Selangor Kedua (RS-2) development plans to build a state that is caring, livable, sustainable and resilient.</div><div><br></div><div>"The healthcare needs of our population are becoming more complex. An ageing population, the growing burden of non-communicable diseases and increasing demand for specialized care require us to continuously strengthen the capacity and capabilities of our healthcare system. For this reason, the State Government welcomes investments that strengthen healthcare capacity and increase accessibility to quality healthcare," he said.</div><div><br></div><div>Speaking at the ceremony, Dato&#039; Lau Beng Long, President of Sunway Healthcare Group, said, "Sunway Medical Centre Damansara brings together a comprehensive range of specialties and subspecialties, supported by advanced diagnostic and therapeutic medical technologies, including AI-enabled and robotic-assisted solutions. As the hospital continues to grow, we are focused on deepening these capabilities and strengthening multidisciplinary care, so that patients can access more complex treatments closer to home.</div><div><br></div><div>"Looking ahead, we are evaluating the next phase of SMCD&#039;s development, with approximately four acres earmarked for future expansion. Our proposed plans include a standalone Sunway Sanctuary focused on senior living and a dedicated Cancer and Nuclear Medicine Centre.</div><div><br></div><div>"The proposed Cancer and Nuclear Medicine Centre is envisioned to incorporate advanced diagnostic and treatment capabilities, including a cyclotron, PET-CT, linear accelerators and CT simulator, as well as Proton Beam Therapy Centre, which would be the first of its kind in Malaysia. These proposed plans reflect our long-term vision to develop SMCD into a more comprehensive healthcare destination, bringing advanced and specialised care for Malaysians and international patients."</div><div><br></div><div>Beyond strengthening its clinical capabilities, SMCD continues to improve accessibility and convenience for the surrounding community. The new ramp connecting Persiaran Surian to Jalan PJU 5/1 provides more direct access to SMCD and Bandar Sunway Damansara. Meanwhile, a link bridge to Sunway Nexis connects patients, visitors and the surrounding community to Surian MRT station, as well as nearby retail, dining and lifestyle amenities, complementing the hospital&#039;s broader efforts to bring advanced healthcare closer to the communities it serves.</div><div><br></div><div>In line with Malaysia&#039;s growing healthcare tourism economy, SMCD is also well positioned to serve medical tourists by virtue of its location within an integrated township, giving patients and accompanying family members convenient access to various amenities. Its connectivity further supports international access, with Subang Airport located nearby and KLIA accessible via a direct drive along the North-South Expressway.</div><div><br></div><div>The hospital&#039;s International Patient Centre supports patients throughout their healthcare journey, with dedicated nurses and translators assisting with specialist appointments, treatment coordination, admissions and communication. SMCD also serves the expatriate community living and working in Malaysia, providing access to specialist care, preventive health services, advanced surgery, rehabilitation and multidisciplinary treatment within the Klang Valley.</div><div><br></div><div>Reflecting on the hospital&#039;s journey, Jasmine Lau Mooi Hun, Chief Executive Officer of SMCD, said, "In a relatively short period, SMCD has grown tremendously in both the breadth of services we provide and the trust that patients, partners and the wider community have placed in us.</div><div><br></div><div>"This progress reflects the dedication of our people and the support of our healthcare partners and stakeholders. As we enter our next phase of growth, we remain committed to strengthening our capabilities, enhancing the patient experience and making comprehensive specialist care more accessible to the communities we serve."</div><div><br></div><div>SMCD achieved its first EBITDA-positive month within nine months of commencing operations, reflecting its strong operational performance and clinical capabilities, and significantly outperforming the industry&#039;s typical ramp-up period of three to five years.</div><div><br></div><div>Building on this strong foundation, SMCD will continue to expand its continuum of care. The hospital will be complemented by ambulatory services at Sunway Specialist Centre Damansara, located across the road, and the planned opening of the Sunway Traditional Chinese Medicine Centre in the first quarter of 2027.</div><div><br></div><div>Together, these services will form a more holistic and integrated healthcare ecosystem, while SMCD continues to strengthen the quality, efficiency and coordination of care to deliver better health outcomes.</div><div><br></div><div>To learn more about Sunway Medical Centre Damansara and its services, visit www.sunwaymedicaldamansara.com.my.</div><div><br></div><div>About Sunway Medical Centre Damansara</div><div>Sunway Medical Centre Damansara (SMCD), located in Kota Damansara, is the fourth tertiary hospital under Sunway Healthcare Group. With a capacity of more than 300 beds, 60 specialist consultation suites and eight operating theatres, SMCD is a multidisciplinary tertiary hospital designed to provide comprehensive and integrated care across a broad range of specialties and subspecialties.</div><div><br></div><div>SMCD offers an extensive range of clinical services across areas including Cardiology, Neurosciences, Gastroenterology & Hepatology, Orthopaedics & Spine, Oncology, Ear, Nose & Throat, Paediatrics, Obstetrics & Gynaecology, Urology, and Plastic & Reconstructive Surgery, among others. Its clinical services are supported by advanced diagnostic and therapeutic medical technologies, including AI-enabled and robotic-assisted solutions, enabling greater precision, more complex interventions and coordinated multidisciplinary care.</div><div><br></div><div>As part of Sunway Healthcare Group, SMCD is supported by the Group&#039;s growing healthcare network.</div><div><br></div><div>For more information or enquiries, please contact the general line at +60 19-216 8825 or +603-8966 9191.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #SunwayMedicalCentreDamansara</div><div><br></div><div>https://www.sunwaymedicaldamansara.com.my/en/</div><div>https://www.linkedin.com/company/sunway-medical-centre-damansara/home/</div><div>https://www.facebook.com/p/Sunway-Medical-Centre-Damansara-61564977045004/</div><div>https://www.instagram.com/sunwaymedicaldamansara/</div>   ]]></description>
<pubDate>Fri, 09 Oct 2026 08:10:00 +0700</pubDate>
</item>
<item>
<title>YYForce Expands 24iFM With Services Marketplace and Lifestyle Advertising</title>
<link>https://relleaseid.com/berita-bisnis/YYForce-Expands-24iFM-With-Services-Marketplace-and-Lifestyle-Advertising</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/5306_YYForce-Expands-24iFM-With-Services-Marketplace-and-Lifestyle-Advertising.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>*Strategic Milestone: Commercial expansion of 24iFM brings estate management, on-demand household services and lifestyle merchant promotions together in one digital platform.</div><div>*Regional Digital Growth: Google, Temasek and Bain & Company&#039;s e-Conomy SEA 2025 report projected Southeast Asia&#039;s digital economy to exceed US$300 billion in gross merchandise value in 2025.</div><div>*Commercial Pathway: Transaction commissions and service fees, together with merchant advertising and promotional revenue, create potential digital revenue streams alongside YYForce&#039;s existing IFM operations.</div><div><br></div><div>SINGAPORE, Oct. 08, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (NASDAQ: YFOR) ("YYForce" or the "Company"), an AI-enabled workforce management platform and integrated facility management ("IFM") provider operating across Asia and beyond, today announced the commercial expansion of 24iFM through its Services Marketplace and Lifestyle advertising capabilities (the "Expansion"). The Expansion brings estate administration, on-demand household services and merchant promotions together in one digital platform.</div><div><br></div><div>The Expansion introduces two potential digital revenue channels alongside YYForce&#039;s existing IFM operations: commissions or service fees from qualifying completed marketplace transactions, and advertising and promotional revenue from participating merchants. Revenue generation will depend on user adoption, completed transactions and commercial agreements with providers and merchants.</div><div><br></div><div>Facility Management to a Digital Services Marketplace</div><div>24iFM integrates functions that have traditionally operated through separate systems. The platform brings together everyday estate and facility management functions - including facility bookings, visitor registration, digital forms, payments and estate communications - with an expanding marketplace of household and property-related services.</div><div><br></div><div>Through the 24iFM Services Marketplace, users can discover and book participating service providers. YYForce expects to participate in qualifying service activity generated through the platform by charging commissions or service fees, subject to applicable commercial arrangements.</div><div><br></div><div>Lifestyle Adds a Digital Advertising Channel</div><div>Alongside the Services Marketplace, YYForce is expanding the 24iFM Lifestyle experience to connect users with participating merchants and service providers across categories such as wellness, education, beauty, health, pet services, sports and other lifestyle segments.</div><div><br></div><div>The Lifestyle capability is designed to create an additional advertising-based revenue opportunity. Potential advertising products include featured merchant placements, sponsored category positions, promotional campaigns and other forms of paid digital visibility.</div><div><br></div><div>Two Monetization Channels in One Digital Ecosystem</div><div>The commercial expansion of 24iFM introduces a complementary digital revenue architecture alongside YYForce&#039;s existing facility management operations. The Services Marketplace is designed to support transaction-based commissions or service fees, while Lifestyle is designed to support advertising and promotional revenue from participating merchants.</div><div><br></div><div>Together, these capabilities are intended to extend the economic potential of YYForce&#039;s property relationships by creating opportunities for digital commercial activity within the communities it serves.</div><div><br></div><div>"24iFM extends our relationship with properties beyond traditional facility management," said Mike Fu, Chairman and Chief Executive Officer of YYForce. "By connecting property users with service providers and merchants through one digital platform, we are building additional transaction and advertising revenue opportunities around our existing IFM footprint. As adoption expands, our objective is to increase the number of commercial interactions that can occur through the 24iFM ecosystem."</div><div><br></div><div>Market Context in Singapore and Southeast Asia</div><div>Singapore provides an initial market for property-connected digital services. According to the Singapore Department of Statistics, Singapore had 381,996 condominiums and other apartments as of June 2026. This housing stock provides context for the types of residential communities 24iFM is designed to serve; it does not represent the Company&#039;s onboarded households or customers.</div><div><br></div><div>24iFM&#039;s expansion takes place against a backdrop of growing regional digital adoption. According to the e-Conomy SEA 2025 report by Google, Temasek and Bain & Company, Southeast Asia&#039;s digital economy was projected to exceed US$300 billion in gross merchandise value in 2025. This broader market figure provides context for regional digital commerce and is not an estimate of 24iFM&#039;s addressable market or expected revenue.</div><div><br></div><div>24iFM&#039;s commercial scope is anchored in its property-connected ecosystem. The platform&#039;s monetization potential will depend on adoption across participating residential and commercial communities, the frequency of completed service bookings, commercial agreements with providers and demand for paid merchant promotions.</div><div><br></div><div>Scaling the 24iFM Ecosystem</div><div>YYForce intends to progressively expand the range of participating service providers, service categories, merchants and commercial offerings available through 24iFM based on market demand and platform adoption.</div><div><br></div><div>As additional properties, users, service providers and merchants participate in the ecosystem, 24iFM is designed to support a growing range of interactions without requiring each new commercial opportunity to operate as a standalone facility management contract.</div><div><br></div><div>The commercialization of 24iFM forms part of YYForce&#039;s broader strategy to combine its operational presence with technology, automation and digital platforms. Within this ecosystem, 24iFM is intended to serve as a digital interaction layer connecting facility operations with everyday services and commercial activity.</div><div><br></div><div>Market Data Sources</div><div><br></div><div>Singapore Department of Statistics, Residential Dwellings, Annual. Data as at end June 2026.&nbsp;</div><div>Google, Temasek and Bain & Company, e-Conomy SEA 2025. Figures are projections published on November 11, 2025.&nbsp;</div><div><br></div><div>About YYForce Inc.</div><div>YYForce Inc. (Nasdaq: YFOR) is an AI-enabled workforce management platform and integrated facility management provider headquartered in Singapore and operating across Asia and beyond. The Company&#039;s intelligent workforce solutions platform, YY Circle, helps clients across hospitality, food and beverage, retail and other service sectors predict, plan and optimize workforce deployment. In YYForce&#039;s IFM business, its 24iFM software platform and comprehensive IFM subsidiary portfolio support clients across hospitality, transportation, banking, retail and mixed-use facilities.</div><div><br></div><div>As both business lines scale, the Company is systematically embedding AI and automation capabilities - progressing from intelligent decision support toward increasingly autonomous workforce management - to improve service quality, reduce deployment costs and drive long-term margin expansion. Listed on the Nasdaq Capital Market, YYForce is committed to infrastructure innovation, measurable client outcomes and long-term value creation.</div><div><br></div><div>Forward Looking Statements</div><div>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company bases these forward-looking statements on its expectations and projections about future events derived from information currently available to it.</div><div><br></div><div> You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. Forward-looking statements include statements regarding the expected development, adoption, commercialization, monetization and expansion of 24iFM and its Services Marketplace and Lifestyle capabilities. Such statements involve risks and uncertainties, and actual events and results may differ materially. </div><div><br></div><div>Factors that could cause actual results to differ materially include, but are not limited to, the Company&#039;s ability to attract and retain users, service providers and merchants to the 24iFM platform, the pace and extent of market adoption, dependence on third-party service providers and commercial arrangements, regulatory developments in markets where the Company operates, competitive conditions, and the Company&#039;s ability to execute its growth and monetization strategy. </div><div><br></div><div>For a more detailed discussion of risk factors, please refer to the Company&#039;s filings with the Securities and Exchange Commission, including the "Risk Factors" section of the Company&#039;s most recent annual report on Form 20-F, as amended. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Fri, 09 Oct 2026 08:05:00 +0700</pubDate>
</item>
<item>
<title>OPPO Find X10 Series to Launch Globally on October 21 with Next-Generation True-to-Life Imaging</title>
<link>https://relleaseid.com/berita-bisnis/OPPO-Find-X10-Series-to-Launch-Globally-on-October-21-with-Next-Generation-True-to-Life-Imaging</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/1913_OPPO-Find-X10-Series-to-Launch-Globally-on-October-21-with-Next-Generation-True-to-Life-Imaging.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>SHENZHEN, CHINA - Media OutReach Newswire - 8 October 2026 - OPPO today announced that its latest flagship smartphones, OPPO Find X10 Series, will make their global debut on October 21 in Mallorca, Spain. Built to be a "Hasselblad True-to-Life Camera", the new series combines industry-leading camera hardware with the next-generation LUMO True Image Engine, marking a new chapter in OPPO&#039;s pursuit of true-to-life imaging.</div><div><br></div><div>"Find X Series reflects our relentless pursuit of exceptional mobile imaging," said Pete Lau, SVP and Chief Product Officer at OPPO. "Together with Hasselblad, we are taking another significant step forward with Find X10 Series, bringing true-to-life detail, color and tone to everyday photography. Simply open the camera and capture the moment as you see it, with no extra settings required."</div><div><br></div><div>Find X10 Series carries forward the Find X Series&#039; minimalist design language with premium materials and thoughtfully crafted details. Its all-new Borderless Design features One-Piece Sculpted Glass that flows seamlessly into the camera module, softening the visual impact of the camera bump for a clean, cohesive look.</div><div><br></div><div>Find X10 Pro Max in Luna White draws design inspiration from classic cameras. Its LUMO Camera Island features a matte silver metallic finish and houses the new-generation True Color Camera and dual-flash system, complemented by knurled detailing and Hasselblad&#039;s signature matte orange accent ring. Across the back, smooth matte glass meets a subtle fabric-inspired pattern in a distinctive two-tone finish.</div><div><br></div><div>Find X10 will be available in Glacier Blue, Glow Coral and Mist Grey, while Find X10 Pro Max will come in Titanium Grey and Luna White.</div><div><br></div><div>The series pairs this refined design with a major leap in imaging hardware. Find X10 features a category-first Dual 200MP Camera System co-developed with Hasselblad. Find X10 Pro Max goes even further with the industry&#039;s first Triple 200MP Camera System, bringing 200MP sensors to the ultra-wide, main and telephoto cameras for the first time on a smartphone.</div><div><br></div><div>Making the most of its camera hardware is OPPO&#039;s next-generation computational photography solution, LUMO True Image Engine. It combines OPPO&#039;s imaging expertise with the natural tone rendering of Master Mode, supported by precise color information captured by the True Color Camera. LUMO True Image Engine delivers authentic detail, accurate color and natural tone. From nuanced skin tones and fine textures to the natural contrast of a scene, images stay true to the moment as you remember it.</div><div><br></div><div>Find X10 Series also brings a major upgrade to videography. On Find X10 Pro Max, all three rear cameras support 4K 120fps and 8K 30fps video recording, while Find X10 brings the same capabilities to its two 200MP cameras. Find X10 Series also introduces Open Gate Capture, using the sensor&#039;s full imaging area to capture more of the scene and give creators greater freedom to crop and reframe the same footage for landscape, portrait and other formats in post-production.</div><div><br></div><div>Powering Find X10 Series are flagship MediaTek chipsets. Find X10 runs on MediaTek Dimensity 9600M, while Find X10 Pro Max is among the first smartphones to feature the 2nm MediaTek Dimensity 9600 Pro, delivering a major leap in both performance and power efficiency.</div><div><br></div><div>Both models feature an 8,000mAh OPPO Silicon-Carbon Battery?, delivering up to two days of typical use on a single charge. Designed for long-term durability, the battery is also engineered to retain over 80% of its original capacity after five years of typical use.?</div><div><br></div><div>Find X10 Series also features the latest ColorOS 17, bringing a fresh look and smarter everyday experiences. Its new Living Flow Design combines refined visuals with fluid interactions, while AI Mind Pilot with Agent Mode connects agentic AI with files and photos on the phone, helping users complete complex tasks with a single prompt.</div><div><br></div><div>OPPO will reveal full specifications, pricing and availability, alongside more of the series&#039; latest innovations, at the global launch in Mallorca on October 21.</div><div><br></div><div>? Battery capacity may vary by market. Find X10 and Find X10 Pro Max feature a 7,150mAh battery in selected markets.</div><div>? Data from OPPO Lab. Actual battery health may vary depending on settings, usage and environmental conditions.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #OPPO</div>   ]]></description>
<pubDate>Fri, 09 Oct 2026 08:01:00 +0700</pubDate>
</item>
<item>
<title>PKF O&#039;Connor Davies Adopts AI-Enabled DAS Suite Powered by Caseware Verity, and Joins the Caseware Agentic Pioneer Program</title>
<link>https://relleaseid.com/berita-bisnis/PKF-O--039-Connor-Davies-Adopts-AI-Enabled-DAS-Suite-Powered-by-Caseware-Verity--and-Joins-the-Caseware-Agentic-Pioneer-Program</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/1379_PKF-O--039-Connor-Davies-Adopts-AI-Enabled-DAS-Suite-Powered-by-Caseware-Verity--and-Joins-the-Caseware-Agentic-Pioneer-Program.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Top 25 U.S. accounting firm unifies audit methodology with Dynamic Assurance Solution (DAS) and becomes one of a select group of firms co-developing proprietary AI agents on Caseware&#039;s governed platform</div><div><br></div><div>TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Caseware, the leading AI platform for assurance and financial reporting, today announced that PKF O&#039;Connor Davies, one of the nation&#039;s largest accounting, tax and advisory practices, has adopted and implemented the AI-enabled Dynamic Assurance Solution (DAS) Suite powered by Caseware Verity, across its audit practice.</div><div><br></div><div> The firm has also joined the Caseware Agentic Pioneer Program, a strategic co-development initiative that enables it to design and deploy proprietary AI agents on Caseware&#039;s governed platform.</div><div><br></div><div>The DAS Suite, which includes DAS Audit, DAS PCR and DAS EBP, combines a modern, risk-based audit methodology with embedded AI, laying the foundation for an agentic future.</div><div><br></div><div>In addition to the DAS Suite, PKF O&#039;Connor Davies also benefits from tax preparation solutions, Caseware Taxflow, and Caseware IDEA, an audit analytics solution for full-population testing, anomaly detection and audit evidence.</div><div><br></div><div>Unifying Audit Methodology with DAS</div><div><br></div><div>The DAS Suite is an integrated, end-to-end audit platform that connects risk assessment, workpapers, financial reporting and related workflows into a single, secure cloud-native system with unified engagement data. It is powered by a transformative methodology developed by the AICPA, in partnership with audit professionals from leading firms, and enables a data- and risk-driven audit approach that eliminates disconnected tools and repetitive tasks, while enabling greater efficiency, audit quality and client value. &#8203;&#8203;The platform&#039;s intelligent checklists and unified engagement data also enable audit teams to work more consistently and efficiently while maintaining rigorous quality standards.</div><div><br></div><div>"DAS stood out from other audit solutions because it was built by auditors, for auditors," said Kevin J. Keane, chief executive officer, PKF O&#039;Connor Davies. "We&#039;ve had a direct hand in shaping the platform and, together with Caseware Verity, it is a key part of our tech-forward strategy and the continued modernization of our audit approach."</div><div><br></div><div>CPA.com served as a strategic implementation partner throughout the transition, providing guidance on implementation planning, data migration, training, and change management.</div><div><br></div><div>"Technology is an important part of the equation, but it&#039;s also critical to get people, processes and data moving in the same direction," said Kalil Merhib, executive vice president, Growth & Professional Services at CPA.com. "PKF O&#039;Connor Davies approached their transition like the professional leaders they are - with an eye on where audit is headed, not just where it stands today. That&#039;s what sets them up to scale with confidence."</div><div><br></div><div>Building Governed AI Directly into the Engagement with Caseware Verity</div><div><br></div><div>PKF O&#039;Connor Davies&#039; adoption of the DAS Suite by Caseware Verity adds an AI intelligence and orchestration layer that operates directly inside assurance and financial reporting engagements. Unlike standalone AI assistants, copilots or single-task AI agents, Verity works within the engagement itself - drawing on engagement history, firm methodology, supporting documentation and professional standards to help practitioners identify risks, analyze documentation, and navigate through complex work with greater speed and confidence.</div><div><br></div><div>"As PKF O&#039;Connor Davies looked to build a future-ready foundation, it chose DAS powered by Caseware Verity to meet the needs of a growing, forward-thinking practice," said David Marquis, chief executive officer of Caseware. "Our $100 million investment in Caseware Verity means leading firms like PKF O&#039;Connor Davies get a trusted, governed platform to develop AI-enabled workflows, sharpen efficiency and capture growth in the agentic era."</div><div><br></div><div>Shaping Assurance Through the Pioneer Program</div><div><br></div><div>As an Agentic Pioneer Program partner, PKF O&#039;Connor Davies will get priority access to Caseware&#039;s Agent Builder suite, including the Agent Workbench and governed MCP interfaces for firm-side agent development, along with Agent Studio, a no-code environment for building and deploying agents. Agents built by PKF O&#039;Connor Davies will run inside the same governed environment as Caseware Verity, so every agent the firm creates carries the audit trail, methodology and context needed to stand up to regulatory scrutiny ? rather than operating as a disconnected, one-off tool.</div><div><br></div><div>"AI will have a meaningful role in the future of assurance, and we intend to help lead that conversation," said Keane. "The Pioneer Program gives us a seat at the table to develop AI capabilities that serve our people and clients while preserving the rigor and accountability they expect from us."</div><div><br></div><div>"Firms like PKF O&#039;Connor Davies are leaning into the future of agentic audit. They&#039;re moving with intention, helping define what responsible AI looks like for the rest of the profession," said Marquis. "That&#039;s exactly what the Pioneer Program is built for: giving firms a smarter, more powerful and governed platform to build on, where agentic efficiencies are realized in a trusted environment."</div><div><br></div><div>About PKF O&#039;Connor Davies</div><div>PKF O&#039;Connor Davies is a top-tier accounting, tax and advisory practice with a long history of serving domestic and international clients. "Know Greater Value" speaks to the confidence and guidance that our clients realize when they work with us. It reinforces our commitment to delivering the highest levels of value, expertise and service in everything we do. Our clients Know Greater Connections, Know Greater Insights and Know Greater Value. </div><div><br></div><div>"PKF O&#039;Connor Davies" is the brand name under which PKF O&#039;Connor Davies LLP and PKF O&#039;Connor Davies Advisory LLC, independently owned entities, provide professional services in an alternative practice structure in accordance with applicable professional standards. PKF O&#039;Connor Davies LLP is a licensed CPA firm that provides attest services and PKF O&#039;Connor Davies Advisory LLC and its subsidiary entities provide tax and advisory services.</div><div><br></div><div>About Caseware</div><div>Caseware is the leading global AI platform for accounting professionals, serving 23,000+ firms in over 130 countries. Caseware&#039;s platform powers audit, financial reporting, and compliance workflows for firms of every size - from regional practices to the world&#039;s largest networks. Caseware enables the world of audit and accounting to unlock efficiency, deliver excellence, and grow with confidence. Through precision, partnership, and innovation, we are powering trust in the global economy. For more information, visit Caseware.</div><div><br></div><div>About CPA.com</div><div>CPA.com is the trusted partner in accounting and finance transformation, enabling firms and finance teams to evolve and innovate across audit, tax and advisory services. It delivers leading-edge strategies, resources and technologies to help firms and finance teams of all sizes stay ahead of a rapidly changing marketplace, deliver more value to clients, and position for long-term success. CPA.com is an affiliate of the American Institute of CPAs (AICPA). For more information, visit www.CPA.com.&nbsp;</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Fri, 09 Oct 2026 07:55:00 +0700</pubDate>
</item></channel></rss>